{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Cox model execution - 1st article\n",
    "In this notebook, we test the Cox model for the data from the following article : https://doi.org/10.1158/1078-0432.CCR-20-1163."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "from survivalAnalysis.CoxModel import CoxModel"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "coxmodel = CoxModel()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Reading and preprocessing\n",
    "We read the ```data/Supplemental-table1.xlsx``` file, and we drop the non-naive patients from the dataframe."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Anonymous ID</th>\n",
       "      <th>EGA ID</th>\n",
       "      <th>Tumour type</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Line of therapy</th>\n",
       "      <th>Immunotherapy regimen</th>\n",
       "      <th>Cohort</th>\n",
       "      <th>Reason for discontinuation</th>\n",
       "      <th>Best response</th>\n",
       "      <th>Age at advanced disease diagnosis</th>\n",
       "      <th>...</th>\n",
       "      <th>SBS6</th>\n",
       "      <th>SBS7a</th>\n",
       "      <th>SBS7b</th>\n",
       "      <th>SBS7c</th>\n",
       "      <th>SBS13</th>\n",
       "      <th>SBS26</th>\n",
       "      <th>SBS44</th>\n",
       "      <th>Tumour type.1</th>\n",
       "      <th>Exome mut per mb.1</th>\n",
       "      <th>Genome mut per mb.1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>23701</td>\n",
       "      <td>EGAD00001002576</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>F</td>\n",
       "      <td>7</td>\n",
       "      <td>GEMCITABINE, VINORELBINE, PEMBROLIZUMAB (ARIZONA)</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression/death</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>30</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.058643</td>\n",
       "      <td>0.219746</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>5.617878</td>\n",
       "      <td>7.0476</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>25980</td>\n",
       "      <td>EGAD00001002997</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>F</td>\n",
       "      <td>5</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Partial response</td>\n",
       "      <td>59</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.068387</td>\n",
       "      <td>0.080349</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>6.853812</td>\n",
       "      <td>9.3941</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>30221</td>\n",
       "      <td>EGAD00001003607</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>F</td>\n",
       "      <td>1</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>53</td>\n",
       "      <td>...</td>\n",
       "      <td>0.055076</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.046292</td>\n",
       "      <td>0.109279</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>6.853812</td>\n",
       "      <td>7.3266</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>31031</td>\n",
       "      <td>EGAD00001003720</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>TRASTUZUMAB, DURVALUMAB</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>49</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.049116</td>\n",
       "      <td>0.102175</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>7.134706</td>\n",
       "      <td>8.3420</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>33532</td>\n",
       "      <td>EGAD00001004623</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>F</td>\n",
       "      <td>6</td>\n",
       "      <td>NIVOLUMAB (P1T986205),BMS-986205 (P1T986205)/I...</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>68</td>\n",
       "      <td>...</td>\n",
       "      <td>0.081547</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.054670</td>\n",
       "      <td>0.157417</td>\n",
       "      <td>0.068070</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>5.084180</td>\n",
       "      <td>5.9052</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>37970</td>\n",
       "      <td>EGAD00001004706</td>\n",
       "      <td>CHOL</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Tremelimumab, Durvalumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>59</td>\n",
       "      <td>...</td>\n",
       "      <td>0.089383</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.048926</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>CHOL</td>\n",
       "      <td>1.825810</td>\n",
       "      <td>2.5119</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>25419</td>\n",
       "      <td>EGAD00001002611</td>\n",
       "      <td>COLO</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>48</td>\n",
       "      <td>...</td>\n",
       "      <td>0.239516</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.059283</td>\n",
       "      <td>0.034684</td>\n",
       "      <td>0.076539</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>COLO</td>\n",
       "      <td>2.724671</td>\n",
       "      <td>4.3225</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>25589</td>\n",
       "      <td>EGAD00001002628</td>\n",
       "      <td>COLO</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed PR</td>\n",
       "      <td>55</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.369304</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>COLO</td>\n",
       "      <td>16.348026</td>\n",
       "      <td>16.0194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>25604</td>\n",
       "      <td>EGAD00001002632</td>\n",
       "      <td>GCT</td>\n",
       "      <td>M</td>\n",
       "      <td>5</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>26</td>\n",
       "      <td>...</td>\n",
       "      <td>0.052485</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.087626</td>\n",
       "      <td>0.062000</td>\n",
       "      <td>0.036009</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>GCT</td>\n",
       "      <td>3.202191</td>\n",
       "      <td>5.2737</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>32395</td>\n",
       "      <td>EGAD00001003734</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>M</td>\n",
       "      <td>1</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>71</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.509550</td>\n",
       "      <td>0.490450</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>62.948328</td>\n",
       "      <td>96.0990</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>36067</td>\n",
       "      <td>EGAD00001004655</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>M</td>\n",
       "      <td>4</td>\n",
       "      <td>Tremelimumab, Durvalumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>56</td>\n",
       "      <td>...</td>\n",
       "      <td>0.113161</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.053110</td>\n",
       "      <td>0.157669</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>7.836940</td>\n",
       "      <td>7.5363</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>34159</td>\n",
       "      <td>EGAD00001004633</td>\n",
       "      <td>KDNY</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed PR</td>\n",
       "      <td>47</td>\n",
       "      <td>...</td>\n",
       "      <td>0.100529</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.056158</td>\n",
       "      <td>0.057500</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>KDNY</td>\n",
       "      <td>1.825810</td>\n",
       "      <td>2.4997</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>25966</td>\n",
       "      <td>EGAD00001003617</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>66</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.069541</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>12.724495</td>\n",
       "      <td>23.2112</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>26016</td>\n",
       "      <td>EGAD00001003005</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed PD</td>\n",
       "      <td>59</td>\n",
       "      <td>...</td>\n",
       "      <td>0.072278</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.132511</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>2.640403</td>\n",
       "      <td>3.9165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>26123</td>\n",
       "      <td>EGAD00001003011</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>3</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>47</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.039168</td>\n",
       "      <td>0.035931</td>\n",
       "      <td>0.028665</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>11.179578</td>\n",
       "      <td>18.6991</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>28132</td>\n",
       "      <td>EGAD00001004903</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed PD</td>\n",
       "      <td>72</td>\n",
       "      <td>...</td>\n",
       "      <td>0.225123</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.045243</td>\n",
       "      <td>0.051324</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.072171</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>1.376380</td>\n",
       "      <td>1.4563</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>28668</td>\n",
       "      <td>EGAD00001003650</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>3</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed PD</td>\n",
       "      <td>69</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.078705</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>9.887466</td>\n",
       "      <td>17.4565</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>30822</td>\n",
       "      <td>EGAD00001003661</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>60</td>\n",
       "      <td>...</td>\n",
       "      <td>0.195922</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.180447</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.142450</td>\n",
       "      <td>0.229384</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>47.414894</td>\n",
       "      <td>60.9330</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>30897</td>\n",
       "      <td>EGAD00001003657</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Tremelimumab, Durvalumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>65</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.065212</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>11.376204</td>\n",
       "      <td>20.2500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>32558</td>\n",
       "      <td>EGAD00001003717</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed PD</td>\n",
       "      <td>45</td>\n",
       "      <td>...</td>\n",
       "      <td>0.272004</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.038504</td>\n",
       "      <td>0.033559</td>\n",
       "      <td>0.034928</td>\n",
       "      <td>0.105226</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>2.022436</td>\n",
       "      <td>2.1248</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>35337</td>\n",
       "      <td>EGAD00001004650</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>64</td>\n",
       "      <td>...</td>\n",
       "      <td>0.067606</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.049474</td>\n",
       "      <td>0.029905</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>2.949386</td>\n",
       "      <td>4.4516</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>36962</td>\n",
       "      <td>EGAD00001004669</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>1</td>\n",
       "      <td>Tremelimumab, Durvalumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>28</td>\n",
       "      <td>...</td>\n",
       "      <td>0.110081</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.034694</td>\n",
       "      <td>0.065584</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>4.297677</td>\n",
       "      <td>6.2113</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>37027</td>\n",
       "      <td>EGAD00001004673</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed PD</td>\n",
       "      <td>45</td>\n",
       "      <td>...</td>\n",
       "      <td>0.196900</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.047937</td>\n",
       "      <td>0.035946</td>\n",
       "      <td>0.083846</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>2.219062</td>\n",
       "      <td>2.8882</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>37719</td>\n",
       "      <td>EGAD00001004693</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed PD</td>\n",
       "      <td>52</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>4.072962</td>\n",
       "      <td>6.9433</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>39280</td>\n",
       "      <td>EGAD00001004933</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Physician Assessed SD</td>\n",
       "      <td>60</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.340920</td>\n",
       "      <td>0.659080</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>84.998501</td>\n",
       "      <td>96.4079</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>21392</td>\n",
       "      <td>EGAD00001002544</td>\n",
       "      <td>OV</td>\n",
       "      <td>F</td>\n",
       "      <td>6</td>\n",
       "      <td>Monalizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>57</td>\n",
       "      <td>...</td>\n",
       "      <td>0.096676</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.053518</td>\n",
       "      <td>0.060896</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>OV</td>\n",
       "      <td>2.415688</td>\n",
       "      <td>4.1274</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>28212</td>\n",
       "      <td>EGAD00001003073</td>\n",
       "      <td>PANC</td>\n",
       "      <td>F</td>\n",
       "      <td>2</td>\n",
       "      <td>Durvalumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>51</td>\n",
       "      <td>...</td>\n",
       "      <td>0.240071</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.077310</td>\n",
       "      <td>0.029778</td>\n",
       "      <td>0.065792</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>PANC</td>\n",
       "      <td>1.938168</td>\n",
       "      <td>2.4923</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>23764</td>\n",
       "      <td>EGAD00001002583</td>\n",
       "      <td>SARC</td>\n",
       "      <td>M</td>\n",
       "      <td>5</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>59</td>\n",
       "      <td>...</td>\n",
       "      <td>0.056856</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.061060</td>\n",
       "      <td>0.027376</td>\n",
       "      <td>0.027478</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>SARC</td>\n",
       "      <td>1.404470</td>\n",
       "      <td>2.7140</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>21516</td>\n",
       "      <td>EGAD00001002546</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Ipilimumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>29</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.789129</td>\n",
       "      <td>0.210871</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>6.235845</td>\n",
       "      <td>11.4871</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>23808</td>\n",
       "      <td>EGAD00001002585</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>F</td>\n",
       "      <td>5</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>66</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.362836</td>\n",
       "      <td>0.134224</td>\n",
       "      <td>0.176404</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>17.612049</td>\n",
       "      <td>33.6950</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>28224</td>\n",
       "      <td>EGAD00001003603</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>M</td>\n",
       "      <td>1</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Patient choice</td>\n",
       "      <td>Physician assessed PR</td>\n",
       "      <td>48</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.756330</td>\n",
       "      <td>0.243670</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>23.875983</td>\n",
       "      <td>40.1297</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>36063</td>\n",
       "      <td>EGAD00001004653</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>M</td>\n",
       "      <td>1</td>\n",
       "      <td>NIVOLUMAB (P1T986205),BMS-986205 (P1T986205)</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>57</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.621552</td>\n",
       "      <td>0.188766</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>8.482996</td>\n",
       "      <td>14.0202</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>37013</td>\n",
       "      <td>EGAD00001005831</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>NIVOLUMAB (P1T986205),BMS-986205 (P1T986205)/I...</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>Partial Response</td>\n",
       "      <td>70</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.742423</td>\n",
       "      <td>0.257577</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>38.735272</td>\n",
       "      <td>64.3748</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>27792</td>\n",
       "      <td>EGAD00001003059</td>\n",
       "      <td>UCEC</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>Monalizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>56</td>\n",
       "      <td>...</td>\n",
       "      <td>0.112021</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.133887</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>UCEC</td>\n",
       "      <td>1.881989</td>\n",
       "      <td>2.8383</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>34211</td>\n",
       "      <td>EGAD00001004636</td>\n",
       "      <td>UCEC</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>NIVOLUMAB (P1T986205),BMS-986205 (P1T986205)/I...</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Progressive disease</td>\n",
       "      <td>39</td>\n",
       "      <td>...</td>\n",
       "      <td>0.178648</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.068630</td>\n",
       "      <td>0.036416</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>UCEC</td>\n",
       "      <td>4.129141</td>\n",
       "      <td>4.8210</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>35 rows × 35 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Anonymous ID           EGA ID Tumour type Sex  Line of therapy   \n",
       "0          23701  EGAD00001002576        BRCA   F                7  \\\n",
       "1          25980  EGAD00001002997        BRCA   F                5   \n",
       "2          30221  EGAD00001003607        BRCA   F                1   \n",
       "3          31031  EGAD00001003720        BRCA   F                4   \n",
       "4          33532  EGAD00001004623        BRCA   F                6   \n",
       "5          37970  EGAD00001004706        CHOL   M                2   \n",
       "6          25419  EGAD00001002611        COLO   M                2   \n",
       "7          25589  EGAD00001002628        COLO   F                4   \n",
       "8          25604  EGAD00001002632         GCT   M                5   \n",
       "9          32395  EGAD00001003734        HNSC   M                1   \n",
       "10         36067  EGAD00001004655        HNSC   M                4   \n",
       "12         34159  EGAD00001004633        KDNY   M                2   \n",
       "13         25966  EGAD00001003617        LUNG   F                3   \n",
       "14         26016  EGAD00001003005        LUNG   F                3   \n",
       "15         26123  EGAD00001003011        LUNG   M                3   \n",
       "16         28132  EGAD00001004903        LUNG   M                2   \n",
       "17         28668  EGAD00001003650        LUNG   M                3   \n",
       "18         30822  EGAD00001003661        LUNG   F                3   \n",
       "19         30897  EGAD00001003657        LUNG   M                2   \n",
       "20         32558  EGAD00001003717        LUNG   M                2   \n",
       "21         35337  EGAD00001004650        LUNG   M                2   \n",
       "22         36962  EGAD00001004669        LUNG   F                1   \n",
       "23         37027  EGAD00001004673        LUNG   F                3   \n",
       "25         37719  EGAD00001004693        LUNG   F                3   \n",
       "26         39280  EGAD00001004933        LUNG   M                2   \n",
       "27         21392  EGAD00001002544          OV   F                6   \n",
       "28         28212  EGAD00001003073        PANC   F                2   \n",
       "29         23764  EGAD00001002583        SARC   M                5   \n",
       "30         21516  EGAD00001002546        SKCM   F                3   \n",
       "31         23808  EGAD00001002585        SKCM   F                5   \n",
       "32         28224  EGAD00001003603        SKCM   M                1   \n",
       "34         36063  EGAD00001004653        SKCM   M                1   \n",
       "35         37013  EGAD00001005831        SKCM   F                3   \n",
       "36         27792  EGAD00001003059        UCEC   F                4   \n",
       "37         34211  EGAD00001004636        UCEC   F                4   \n",
       "\n",
       "                                Immunotherapy regimen Cohort   \n",
       "0   GEMCITABINE, VINORELBINE, PEMBROLIZUMAB (ARIZONA)  Naive  \\\n",
       "1                                       Pembrolizumab  Naive   \n",
       "2                                       Pembrolizumab  Naive   \n",
       "3                             TRASTUZUMAB, DURVALUMAB  Naive   \n",
       "4   NIVOLUMAB (P1T986205),BMS-986205 (P1T986205)/I...  Naive   \n",
       "5                            Tremelimumab, Durvalumab  Naive   \n",
       "6                                        Atezolizumab  Naive   \n",
       "7                                           Nivolumab  Naive   \n",
       "8                                        Atezolizumab  Naive   \n",
       "9                                       Pembrolizumab  Naive   \n",
       "10                           Tremelimumab, Durvalumab  Naive   \n",
       "12                                          Nivolumab  Naive   \n",
       "13                                          Nivolumab  Naive   \n",
       "14                                          Nivolumab  Naive   \n",
       "15                                          Nivolumab  Naive   \n",
       "16                                          Nivolumab  Naive   \n",
       "17                                          Nivolumab  Naive   \n",
       "18                                          Nivolumab  Naive   \n",
       "19                           Tremelimumab, Durvalumab  Naive   \n",
       "20                                          Nivolumab  Naive   \n",
       "21                                          Nivolumab  Naive   \n",
       "22                           Tremelimumab, Durvalumab  Naive   \n",
       "23                                          Nivolumab  Naive   \n",
       "25                                          Nivolumab  Naive   \n",
       "26                                      Pembrolizumab  Naive   \n",
       "27                                        Monalizumab  Naive   \n",
       "28                                         Durvalumab  Naive   \n",
       "29                                       Atezolizumab  Naive   \n",
       "30                                         Ipilimumab  Naive   \n",
       "31                                      Pembrolizumab  Naive   \n",
       "32                                          Nivolumab  Naive   \n",
       "34       NIVOLUMAB (P1T986205),BMS-986205 (P1T986205)  Naive   \n",
       "35  NIVOLUMAB (P1T986205),BMS-986205 (P1T986205)/I...  Naive   \n",
       "36                                        Monalizumab  Naive   \n",
       "37  NIVOLUMAB (P1T986205),BMS-986205 (P1T986205)/I...  Naive   \n",
       "\n",
       "   Reason for discontinuation          Best response   \n",
       "0           Progression/death    Progressive disease  \\\n",
       "1                 Progression       Partial response   \n",
       "2                 Progression    Progressive disease   \n",
       "3                 Progression    Progressive disease   \n",
       "4                 Progression         Stable disease   \n",
       "5                 Progression    Progressive disease   \n",
       "6                 Progression    Progressive disease   \n",
       "7                 Progression  Physician assessed PR   \n",
       "8                 Progression         Stable disease   \n",
       "9                       Death          Not evaluable   \n",
       "10                Progression    Progressive disease   \n",
       "12                Progression  Physician assessed PR   \n",
       "13                Progression  Physician assessed SD   \n",
       "14                Progression  Physician assessed PD   \n",
       "15                Progression          Not evaluable   \n",
       "16                Progression  Physician assessed PD   \n",
       "17                Progression  Physician assessed PD   \n",
       "18                      Death          Not evaluable   \n",
       "19                Progression         Stable disease   \n",
       "20                Progression  Physician assessed PD   \n",
       "21                Progression  Physician assessed SD   \n",
       "22                Progression         Stable disease   \n",
       "23                Progression  Physician assessed PD   \n",
       "25                Progression  Physician assessed PD   \n",
       "26                   Toxicity  Physician Assessed SD   \n",
       "27                Progression  Physician assessed SD   \n",
       "28                Progression    Progressive disease   \n",
       "29                Progression         Stable disease   \n",
       "30                      Death          Not evaluable   \n",
       "31                    Ongoing  Physician assessed SD   \n",
       "32             Patient choice  Physician assessed PR   \n",
       "34                Progression    Progressive disease   \n",
       "35                    Ongoing       Partial Response   \n",
       "36                Progression    Progressive disease   \n",
       "37                Progression    Progressive disease   \n",
       "\n",
       "    Age at advanced disease diagnosis  ...      SBS6     SBS7a     SBS7b   \n",
       "0                                  30  ...  0.000000  0.000000  0.000000  \\\n",
       "1                                  59  ...  0.000000  0.000000  0.000000   \n",
       "2                                  53  ...  0.055076  0.000000  0.000000   \n",
       "3                                  49  ...  0.000000  0.000000  0.000000   \n",
       "4                                  68  ...  0.081547  0.000000  0.000000   \n",
       "5                                  59  ...  0.089383  0.000000  0.000000   \n",
       "6                                  48  ...  0.239516  0.000000  0.000000   \n",
       "7                                  55  ...  0.000000  0.000000  0.000000   \n",
       "8                                  26  ...  0.052485  0.000000  0.087626   \n",
       "9                                  71  ...  0.000000  0.509550  0.490450   \n",
       "10                                 56  ...  0.113161  0.000000  0.000000   \n",
       "12                                 47  ...  0.100529  0.000000  0.000000   \n",
       "13                                 66  ...  0.000000  0.000000  0.000000   \n",
       "14                                 59  ...  0.072278  0.000000  0.000000   \n",
       "15                                 47  ...  0.000000  0.000000  0.039168   \n",
       "16                                 72  ...  0.225123  0.000000  0.045243   \n",
       "17                                 69  ...  0.000000  0.000000  0.000000   \n",
       "18                                 60  ...  0.195922  0.000000  0.000000   \n",
       "19                                 65  ...  0.000000  0.000000  0.000000   \n",
       "20                                 45  ...  0.272004  0.000000  0.038504   \n",
       "21                                 64  ...  0.067606  0.000000  0.000000   \n",
       "22                                 28  ...  0.110081  0.000000  0.000000   \n",
       "23                                 45  ...  0.196900  0.000000  0.000000   \n",
       "25                                 52  ...  0.000000  0.000000  0.000000   \n",
       "26                                 60  ...  0.000000  0.340920  0.659080   \n",
       "27                                 57  ...  0.096676  0.000000  0.053518   \n",
       "28                                 51  ...  0.240071  0.000000  0.000000   \n",
       "29                                 59  ...  0.056856  0.000000  0.000000   \n",
       "30                                 29  ...  0.000000  0.789129  0.210871   \n",
       "31                                 66  ...  0.000000  0.362836  0.134224   \n",
       "32                                 48  ...  0.000000  0.756330  0.243670   \n",
       "34                                 57  ...  0.000000  0.621552  0.188766   \n",
       "35                                 70  ...  0.000000  0.742423  0.257577   \n",
       "36                                 56  ...  0.112021  0.000000  0.000000   \n",
       "37                                 39  ...  0.178648  0.000000  0.000000   \n",
       "\n",
       "       SBS7c     SBS13     SBS26     SBS44  Tumour type.1  Exome mut per mb.1   \n",
       "0   0.058643  0.219746  0.000000  0.000000           BRCA            5.617878  \\\n",
       "1   0.068387  0.080349  0.000000  0.000000           BRCA            6.853812   \n",
       "2   0.046292  0.109279  0.000000  0.000000           BRCA            6.853812   \n",
       "3   0.049116  0.102175  0.000000  0.000000           BRCA            7.134706   \n",
       "4   0.054670  0.157417  0.068070  0.000000           BRCA            5.084180   \n",
       "5   0.048926  0.000000  0.000000  0.000000           CHOL            1.825810   \n",
       "6   0.059283  0.034684  0.076539  0.000000           COLO            2.724671   \n",
       "7   0.000000  0.369304  0.000000  0.000000           COLO           16.348026   \n",
       "8   0.062000  0.036009  0.000000  0.000000            GCT            3.202191   \n",
       "9   0.000000  0.000000  0.000000  0.000000           HNSC           62.948328   \n",
       "10  0.053110  0.157669  0.000000  0.000000           HNSC            7.836940   \n",
       "12  0.056158  0.057500  0.000000  0.000000           KDNY            1.825810   \n",
       "13  0.000000  0.069541  0.000000  0.000000           LUNG           12.724495   \n",
       "14  0.000000  0.132511  0.000000  0.000000           LUNG            2.640403   \n",
       "15  0.035931  0.028665  0.000000  0.000000           LUNG           11.179578   \n",
       "16  0.051324  0.000000  0.072171  0.000000           LUNG            1.376380   \n",
       "17  0.000000  0.078705  0.000000  0.000000           LUNG            9.887466   \n",
       "18  0.180447  0.000000  0.142450  0.229384           LUNG           47.414894   \n",
       "19  0.000000  0.065212  0.000000  0.000000           LUNG           11.376204   \n",
       "20  0.033559  0.034928  0.105226  0.000000           LUNG            2.022436   \n",
       "21  0.049474  0.029905  0.000000  0.000000           LUNG            2.949386   \n",
       "22  0.000000  0.034694  0.065584  0.000000           LUNG            4.297677   \n",
       "23  0.047937  0.035946  0.083846  0.000000           LUNG            2.219062   \n",
       "25  0.000000  0.000000  0.000000  0.000000           LUNG            4.072962   \n",
       "26  0.000000  0.000000  0.000000  0.000000           LUNG           84.998501   \n",
       "27  0.060896       NaN  0.000000  0.000000             OV            2.415688   \n",
       "28  0.077310  0.029778  0.065792  0.000000           PANC            1.938168   \n",
       "29  0.061060  0.027376  0.027478  0.000000           SARC            1.404470   \n",
       "30  0.000000  0.000000  0.000000  0.000000           SKCM            6.235845   \n",
       "31  0.176404  0.000000  0.000000  0.000000           SKCM           17.612049   \n",
       "32  0.000000  0.000000  0.000000  0.000000           SKCM           23.875983   \n",
       "34  0.000000  0.000000  0.000000  0.000000           SKCM            8.482996   \n",
       "35  0.000000  0.000000  0.000000  0.000000           SKCM           38.735272   \n",
       "36  0.000000  0.133887  0.000000  0.000000           UCEC            1.881989   \n",
       "37  0.068630  0.036416  0.000000  0.000000           UCEC            4.129141   \n",
       "\n",
       "    Genome mut per mb.1  \n",
       "0                7.0476  \n",
       "1                9.3941  \n",
       "2                7.3266  \n",
       "3                8.3420  \n",
       "4                5.9052  \n",
       "5                2.5119  \n",
       "6                4.3225  \n",
       "7               16.0194  \n",
       "8                5.2737  \n",
       "9               96.0990  \n",
       "10               7.5363  \n",
       "12               2.4997  \n",
       "13              23.2112  \n",
       "14               3.9165  \n",
       "15              18.6991  \n",
       "16               1.4563  \n",
       "17              17.4565  \n",
       "18              60.9330  \n",
       "19              20.2500  \n",
       "20               2.1248  \n",
       "21               4.4516  \n",
       "22               6.2113  \n",
       "23               2.8882  \n",
       "25               6.9433  \n",
       "26              96.4079  \n",
       "27               4.1274  \n",
       "28               2.4923  \n",
       "29               2.7140  \n",
       "30              11.4871  \n",
       "31              33.6950  \n",
       "32              40.1297  \n",
       "34              14.0202  \n",
       "35              64.3748  \n",
       "36               2.8383  \n",
       "37               4.8210  \n",
       "\n",
       "[35 rows x 35 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_excel('data/table-s1-sigmut.xlsx')\n",
    "df = df.loc[df[\"Cohort\"] == \"Naive\"]\n",
    "df"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Compare high risk patients and low risk patients"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### a. Find risk classes\n",
    "With the ```CoxModel``` class implementing a Cox Regression, we can determine the risk class for each sample : high (class 1) or low (class 0). Because we have few data, we use a **leave one out cross validation**, which consists in fitting the model with all the dataset except 1 sample, then we predict the risk class for the test sample."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['Age at advanced disease diagnosis', 'Overall survival (days)',\n",
      "       'Alive_0', 'Time to progression (days)', 'Progression_1',\n",
      "       'CD8+ T cell score', 'Exome mut per mb', 'Genome mut per mb',\n",
      "       'CD274 expression', 'M1M2 expression', 'SBS2', 'SBS4', 'SBS18', 'SBS5',\n",
      "       'SBS6', 'SBS7a', 'SBS7b', 'SBS7c', 'SBS13', 'SBS26', 'SBS44',\n",
      "       'Tumour type.1', 'Exome mut per mb.1', 'Genome mut per mb.1'],\n",
      "      dtype='object')\n"
     ]
    },
    {
     "ename": "KeyError",
     "evalue": "\"None of [Index([ 0,  1,  2,  3,  4,  5,  6,  7,  8,  9, 10, 11, 12, 13, 14, 15, 16, 17,\\n       18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 30, 31, 32, 33, 34],\\n      dtype='int64')] are in the [columns]\"",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[11], line 9\u001b[0m\n\u001b[1;32m      6\u001b[0m \u001b[39mprint\u001b[39m(X\u001b[39m.\u001b[39mcolumns)\n\u001b[1;32m      8\u001b[0m \u001b[39m# Finding the risk classes - TTP\u001b[39;00m\n\u001b[0;32m----> 9\u001b[0m risk_classes_ttp, risk_scores_ttp \u001b[39m=\u001b[39m coxmodel\u001b[39m.\u001b[39;49mleave_one_out_cross_validation(X,y_ttp)\n\u001b[1;32m     10\u001b[0m \u001b[39mprint\u001b[39m(\u001b[39m\"\u001b[39m\u001b[39mTTP :\u001b[39m\u001b[39m\"\u001b[39m)\n\u001b[1;32m     11\u001b[0m \u001b[39mprint\u001b[39m(risk_classes_ttp)\n",
      "File \u001b[0;32m~/Documents/TN/3A/Stage/MEDomics/mutational-signatures/survivalAnalysis/CoxModel.py:92\u001b[0m, in \u001b[0;36mCoxModel.leave_one_out_cross_validation\u001b[0;34m(self, X, y)\u001b[0m\n\u001b[1;32m     88\u001b[0m \u001b[39m# Train - cutoff - test for each fold\u001b[39;00m\n\u001b[1;32m     89\u001b[0m \u001b[39mfor\u001b[39;00m i, (train_index, test_index) \u001b[39min\u001b[39;00m \u001b[39menumerate\u001b[39m(folds):\n\u001b[1;32m     90\u001b[0m     \n\u001b[1;32m     91\u001b[0m     \u001b[39m# Train\u001b[39;00m\n\u001b[0;32m---> 92\u001b[0m     \u001b[39mself\u001b[39m\u001b[39m.\u001b[39mtrain(X[train_index],y[train_index])\n\u001b[1;32m     94\u001b[0m     \u001b[39m# Predict train scores and find cutoff\u001b[39;00m\n\u001b[1;32m     95\u001b[0m     train_scores \u001b[39m=\u001b[39m \u001b[39mself\u001b[39m\u001b[39m.\u001b[39mpredict_risk_score(X[train_index])\n",
      "File \u001b[0;32m~/Documents/TN/3A/Stage/MEDomics/mutational-signatures/venv/lib/python3.10/site-packages/pandas/core/frame.py:3767\u001b[0m, in \u001b[0;36mDataFrame.__getitem__\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m   3765\u001b[0m     \u001b[39mif\u001b[39;00m is_iterator(key):\n\u001b[1;32m   3766\u001b[0m         key \u001b[39m=\u001b[39m \u001b[39mlist\u001b[39m(key)\n\u001b[0;32m-> 3767\u001b[0m     indexer \u001b[39m=\u001b[39m \u001b[39mself\u001b[39;49m\u001b[39m.\u001b[39;49mcolumns\u001b[39m.\u001b[39;49m_get_indexer_strict(key, \u001b[39m\"\u001b[39;49m\u001b[39mcolumns\u001b[39;49m\u001b[39m\"\u001b[39;49m)[\u001b[39m1\u001b[39m]\n\u001b[1;32m   3769\u001b[0m \u001b[39m# take() does not accept boolean indexers\u001b[39;00m\n\u001b[1;32m   3770\u001b[0m \u001b[39mif\u001b[39;00m \u001b[39mgetattr\u001b[39m(indexer, \u001b[39m\"\u001b[39m\u001b[39mdtype\u001b[39m\u001b[39m\"\u001b[39m, \u001b[39mNone\u001b[39;00m) \u001b[39m==\u001b[39m \u001b[39mbool\u001b[39m:\n",
      "File \u001b[0;32m~/Documents/TN/3A/Stage/MEDomics/mutational-signatures/venv/lib/python3.10/site-packages/pandas/core/indexes/base.py:5876\u001b[0m, in \u001b[0;36mIndex._get_indexer_strict\u001b[0;34m(self, key, axis_name)\u001b[0m\n\u001b[1;32m   5873\u001b[0m \u001b[39melse\u001b[39;00m:\n\u001b[1;32m   5874\u001b[0m     keyarr, indexer, new_indexer \u001b[39m=\u001b[39m \u001b[39mself\u001b[39m\u001b[39m.\u001b[39m_reindex_non_unique(keyarr)\n\u001b[0;32m-> 5876\u001b[0m \u001b[39mself\u001b[39;49m\u001b[39m.\u001b[39;49m_raise_if_missing(keyarr, indexer, axis_name)\n\u001b[1;32m   5878\u001b[0m keyarr \u001b[39m=\u001b[39m \u001b[39mself\u001b[39m\u001b[39m.\u001b[39mtake(indexer)\n\u001b[1;32m   5879\u001b[0m \u001b[39mif\u001b[39;00m \u001b[39misinstance\u001b[39m(key, Index):\n\u001b[1;32m   5880\u001b[0m     \u001b[39m# GH 42790 - Preserve name from an Index\u001b[39;00m\n",
      "File \u001b[0;32m~/Documents/TN/3A/Stage/MEDomics/mutational-signatures/venv/lib/python3.10/site-packages/pandas/core/indexes/base.py:5935\u001b[0m, in \u001b[0;36mIndex._raise_if_missing\u001b[0;34m(self, key, indexer, axis_name)\u001b[0m\n\u001b[1;32m   5933\u001b[0m     \u001b[39mif\u001b[39;00m use_interval_msg:\n\u001b[1;32m   5934\u001b[0m         key \u001b[39m=\u001b[39m \u001b[39mlist\u001b[39m(key)\n\u001b[0;32m-> 5935\u001b[0m     \u001b[39mraise\u001b[39;00m \u001b[39mKeyError\u001b[39;00m(\u001b[39mf\u001b[39m\u001b[39m\"\u001b[39m\u001b[39mNone of [\u001b[39m\u001b[39m{\u001b[39;00mkey\u001b[39m}\u001b[39;00m\u001b[39m] are in the [\u001b[39m\u001b[39m{\u001b[39;00maxis_name\u001b[39m}\u001b[39;00m\u001b[39m]\u001b[39m\u001b[39m\"\u001b[39m)\n\u001b[1;32m   5937\u001b[0m not_found \u001b[39m=\u001b[39m \u001b[39mlist\u001b[39m(ensure_index(key)[missing_mask\u001b[39m.\u001b[39mnonzero()[\u001b[39m0\u001b[39m]]\u001b[39m.\u001b[39munique())\n\u001b[1;32m   5938\u001b[0m \u001b[39mraise\u001b[39;00m \u001b[39mKeyError\u001b[39;00m(\u001b[39mf\u001b[39m\u001b[39m\"\u001b[39m\u001b[39m{\u001b[39;00mnot_found\u001b[39m}\u001b[39;00m\u001b[39m not in index\u001b[39m\u001b[39m\"\u001b[39m)\n",
      "\u001b[0;31mKeyError\u001b[0m: \"None of [Index([ 0,  1,  2,  3,  4,  5,  6,  7,  8,  9, 10, 11, 12, 13, 14, 15, 16, 17,\\n       18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 30, 31, 32, 33, 34],\\n      dtype='int64')] are in the [columns]\""
     ]
    }
   ],
   "source": [
    "# Preprocessing for the label data\n",
    "X = df.drop([\"Anonymous ID\",\"EGA ID\",\"Tumour type\",\"Sex\",\"Line of therapy\",\"Immunotherapy regimen\",\"Cohort\",\"Reason for discontinuation\",\"Best response\",\"Clinical benefit\",\"Lymph related\"],axis=1)\n",
    "#X = df.loc[:,[\"Age at advanced disease diagnosis\",\"CD8+ T cell score\",\"Exome mut per mb\",\"Genome mut per mb\",\"CD274 expression\",\"M1M2 expression\"]].to_numpy()\n",
    "y_ttp = np.array(list((df[['Progression_1','Time to progression (days)']].itertuples(index=False, name=None))),dtype=[('Progression_1', '?'), ('Time to progression (days)', '<f8')])\n",
    "y_os = np.array(list((df[['Alive_0','Overall survival (days)']].itertuples(index=False, name=None))),dtype=[('Alive_0', '?'), ('Overall survival (days)', '<f8')])\n",
    "print(X.columns)\n",
    "\n",
    "# Finding the risk classes - TTP\n",
    "risk_classes_ttp, risk_scores_ttp = coxmodel.leave_one_out_cross_validation(X,y_ttp)\n",
    "print(\"TTP :\")\n",
    "print(risk_classes_ttp)\n",
    "print(risk_scores_ttp)\n",
    "\n",
    "# Finding the risk classes - OS\n",
    "print(\"\\n OS :\")\n",
    "risk_classes_os, risk_scores_os = coxmodel.leave_one_out_cross_validation(X,y_os)\n",
    "print(risk_classes_os)\n",
    "print(risk_scores_os)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### b. Compute concordance index\n",
    "In this context, the concordance index measures the proportion of patients comparable pairs in which the risk score and the surviving time are concordant."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "C index (TTP) : 0.57\n",
      "C index (OS) : 0.56\n"
     ]
    }
   ],
   "source": [
    "# TTP : \n",
    "status_ttp, time_ttp = df['Progression_1'].to_numpy().astype(bool), df['Time to progression (days)'].to_numpy()\n",
    "c_index_ttp = coxmodel.get_c_index(status_ttp, time_ttp, risk_scores_ttp)\n",
    "print(f\"C index (TTP) : {c_index_ttp}\")\n",
    "\n",
    "# OS :\n",
    "status_os, time_os = df['Alive_0'].to_numpy().astype(bool), df['Overall survival (days)'].to_numpy()\n",
    "c_index_os = coxmodel.get_c_index(status_os, time_os, risk_scores_os)\n",
    "print(f\"C index (OS) : {c_index_os}\")"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### c. Compute p value of the log rank test\n",
    "The log rank test compares 2 survival curves. If the p value is low (under 5%), the 2 curves are different. Otherwise, the 2 curves are pretty similar. We make this test for the low risk (class 0) and high risk curves (class 1)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "p value (TTP) : 0.04\n",
      "p value (OS) : 0.19\n"
     ]
    }
   ],
   "source": [
    "# TTP :\n",
    "p_value_ttp = coxmodel.log_rank_test(status_ttp.astype(int), time_ttp, risk_classes_ttp)\n",
    "print(f\"p value (TTP) : {p_value_ttp}\")\n",
    "\n",
    "# OS :\n",
    "p_value_os = coxmodel.log_rank_test(status_os.astype(int), time_os, risk_classes_os)\n",
    "print(f\"p value (OS) : {p_value_os}\")"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### d. Vizualize survival curves for each class"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "TTP : \n",
      "n_samples low risk : 38\n",
      "n_samples high risk : 44\n",
      "\n",
      " OS : \n",
      "n_samples low risk : 40\n",
      "n_samples high risk : 42\n"
     ]
    }
   ],
   "source": [
    "# TTP :\n",
    "print(\"TTP : \")\n",
    "# Low risk class\n",
    "status_low_ttp, time_low_ttp = status_ttp[np.where(risk_classes_ttp==0)], time_ttp[np.where(risk_classes_ttp==0)]\n",
    "time_axis_low_ttp, prob_axis_low_ttp = coxmodel.kaplan_meier_estimation(status_low_ttp, time_low_ttp)\n",
    "# High risk class\n",
    "status_high_ttp, time_high_ttp = status_ttp[np.where(risk_classes_ttp==1)], time_ttp[np.where(risk_classes_ttp==1)]\n",
    "time_axis_high_ttp, prob_axis_high_ttp = coxmodel.kaplan_meier_estimation(status_high_ttp, time_high_ttp)\n",
    "print(f\"n_samples low risk : {status_low_ttp.shape[0]}\")\n",
    "print(f\"n_samples high risk : {status_high_ttp.shape[0]}\")\n",
    "\n",
    "# OS :\n",
    "print(\"\\n OS : \")\n",
    "# Low risk class\n",
    "status_low_os, time_low_os = status_os[np.where(risk_classes_os==0)], time_os[np.where(risk_classes_os==0)]\n",
    "time_axis_low_os, prob_axis_low_os = coxmodel.kaplan_meier_estimation(status_low_os, time_low_os)\n",
    "# High risk class\n",
    "status_high_os, time_high_os = status_os[np.where(risk_classes_os==1)], time_os[np.where(risk_classes_os==1)]\n",
    "time_axis_high_os, prob_axis_high_os = coxmodel.kaplan_meier_estimation(status_high_os, time_high_os)\n",
    "print(f\"n_samples low risk : {status_low_os.shape[0]}\")\n",
    "print(f\"n_samples high risk : {status_high_os.shape[0]}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABNEAAAJwCAYAAACnPPcPAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/bCgiHAAAACXBIWXMAAA9hAAAPYQGoP6dpAADA+UlEQVR4nOzdeVyU1fv/8fcNsg0oroAZueeumKbihFofzbQ0LdOyUsnsW7mlmUuLS33UFjXLFstKs4+VrbarqVk0appGq1rmWglqqciMCsL9+4MfkyPDMjgwA7yej8c8Ys6c+76vYWmO133OuQzTNE0BAAAAAAAAyFeArwMAAAAAAAAA/B1JNAAAAAAAAKAQJNEAAAAAAACAQpBEAwAAAAAAAApBEg0AAAAAAAAoBEk0AAAAAAAAoBAk0QAAAAAAAIBCkEQDAAAAAAAACkESDQAAAAAAACgESTSgHBo2bJjq1avn6zBK1N69e2UYhubMmeO1c06fPl2GYejIkSOF9q1Xr56GDRvmfL5+/XoZhqH169c72/zt5+AuxrKkW7du6tatm6/DyOPxxx9X06ZNlZ2d7etQdOONN2rgwIG+DgMAKoTS+Jw3DEPTp08v0Wt4gvGX5xh/lYzSHn9NnjxZHTt2LJVrwb+RRINXLFmyRIZhKDQ0VH/++Wee17t166aWLVv6IDLAfzgcDk2fPr3MDqJKwy+//KLp06dr7969vg6lSNLS0vTYY49p0qRJCggI0LBhw2QYRqEPT/pJOf8PPbu9evXquvTSS/XKK6+4DB4nTZqkd999V99//72PviMAUDJ+/PFHDRgwQHXr1lVoaKjq1KmjHj16aMGCBb4ODX6O8Vfhyvr462x2u12PPPKIWrduLYvFosjISCUkJGjp0qUyTTPPudLT0zVt2jS1bNlS4eHhqlGjhuLi4jR27Fj99ddfzn733HOPvv/+e3344Ycl/v7g3yr5OgCUL6dPn9ajjz7KgMbHFi1a5BezYsqznTt35vnQPte5PweHw6EZM2ZIkl/e0fMHv/zyi2bMmKFu3brluYu8evVq3wRVgFdeeUVnzpzRTTfdJEn6v//7P3Xv3t35+p49ezR16lTdcccdSkhIcLY3bNiwyP1yXXjhhZo9e7Yk6fDhw1q6dKmGDx+uX3/9VY8++qgkqW3btmrfvr3mzp2rpUuXlsybBoBStmHDBl1++eW66KKLNGLECMXExOjAgQPatGmTnnrqKY0ePdoncTHeKn2Mv0pGWR9/5UpNTdV//vMfbd++XTfeeKNGjRqlU6dO6d1339XQoUP16aefatmyZQoMDJQkZWZmqkuXLtqxY4eGDh2q0aNHKz09XT///LNef/119e/fXxdccIEkKSYmRtdee63mzJmjvn37lvp7hv8giQaviouL06JFizRlyhTn/3D8zZkzZ5Sdna3g4OASv1Z2drYyMjIUGhpa4tc6W1BQUKlez1scDocsFouvwyiSkJCQQvuU1Z+DvyqNv1lPLV68WH379nX+jcfHxys+Pt75+rfffqupU6cqPj5et9xyi8uxRe2XKzIy0uW1//u//1OTJk30zDPP6JFHHnH+vg0cOFDTpk3Tc889p4iICK+9VwDwlZkzZyoyMlJbtmxR1apVXV47dOiQ165jt9sVHh5e5P7l5XOe8RcKUhbGX7mGDh2q7du36/3333dJdI0ZM0b33Xef5syZo7Zt22rSpEmSpBUrVui7777TsmXLNHjwYJdznTp1ShkZGS5tAwcO1A033KDdu3erQYMGJfTu4O9Yzgmvuv/++5WVleWcFVGQM2fO6JFHHlHDhg0VEhKievXq6f7779fp06cLPXbYsGGKiIjQ7t271bNnT4WHh+uCCy7Qww8/7DJN9+x9G+bPn++81i+//CJJWrdunRISEhQeHq6qVavq2muv1fbt2/Ncb/369Wrfvr1CQ0PVsGFDvfDCC879G85mGIZGjRqlZcuWqUWLFgoJCdHKlSslSX/++aduu+02RUdHKyQkRC1atNArr7yS51oLFixQixYtZLFYVK1aNbVv316vv/668/UTJ07onnvuUb169RQSEqKoqCj16NFD27Ztc/n+nHsXyW63695771VsbKxCQkLUpEkTzZkzJ8+05tz3sGLFCrVs2dIZa+77KEjung/Lly/X/fffr5iYGIWHh6tv3746cOCAS9/cJb5bt25Vly5dZLFYdP/990vKGRAPHz5c0dHRCg0NVZs2bfTqq6/me90nn3xSdevWVVhYmLp27aqffvrJ5fUffvhBw4YNU4MGDRQaGqqYmBjddttt+vvvv92e78iRIxo4cKCqVKmiGjVqaOzYsTp16pRLn3P35HDn7J/D3r17VatWLUnSjBkznMvypk+frsWLF8swDH333Xd5zjFr1iwFBga6XSada9++fbr77rvVpEkThYWFqUaNGrrhhhuKPCX/7bffVrt27RQWFqaaNWvqlltuyXO93L+5P//8U/369VNERIRq1aqlCRMmKCsry6Xv33//rVtvvVVVqlRR1apVNXToUH3//fcyDENLlizJN44lS5bohhtukCRdfvnlzu9R7vKLc/fkyP19e+uttzRjxgzVqVNHlStX1oABA3T8+HGdPn1a99xzj6KiohQREaHExES3/3/53//+53z/1atX14033pjn99WdPXv26IcffnCZUVaaLBaLOnXqJLvdrsOHDzvbe/ToIbvdrs8//9wncQGAt/3+++9q0aJFngSaJEVFRTm/zh33ufusOXdvsdxx3C+//KLBgwerWrVquuyyyzRnzhwZhqF9+/blOceUKVMUHByso0ePSnL9nM/MzFT16tWVmJiY57i0tDSFhoZqwoQJkqSMjAxNnTpV7dq1U2RkpMLDw5WQkKAvvvjCg+/Kvxh/uWL8VTHHX5s2bdKqVas0bNgwtzPFZs+ercaNG+uxxx7TyZMnJeX8v0WSrFZrnv6hoaGqUqWKS1vuNT/44INC40T5xUw0eFX9+vU1ZMgQLVq0SJMnTy5wNtrtt9+uV199VQMGDNC9996rb775RrNnz3bePShMVlaWrrrqKnXq1EmPP/64Vq5cqWnTpunMmTN6+OGHXfouXrxYp06d0h133KGQkBBVr15da9asUa9evdSgQQNNnz5dJ0+e1IIFC2S1WrVt2zbnh+93332nq666SrVr19aMGTOUlZWlhx9+2PmBfK5169bprbfe0qhRo1SzZk3Vq1dPqamp6tSpkzNBVatWLX322WcaPny40tLSdM8990jKmX4+ZswYDRgwwDlw+OGHH/TNN984747ceeedeueddzRq1Cg1b95cf//9t77++mtt375dl1xyiduYTNNU37599cUXX2j48OGKi4vTqlWrdN999+nPP//Uk08+6dL/66+/1nvvvae7775blStX1tNPP63rr79e+/fvV40aNQr92cycOVOGYWjSpEk6dOiQ5s+fr+7duys5OVlhYWHOfn///bd69eqlG2+8Ubfccouio6N18uRJdevWTbt27dKoUaNUv359vf322xo2bJiOHTumsWPHulxr6dKlOnHihEaOHKlTp07pqaee0hVXXKEff/xR0dHRkqTPP/9cu3fvVmJiomJiYvTzzz/rxRdf1M8//6xNmzblSYYOHDhQ9erV0+zZs7Vp0yY9/fTTOnr06Hktj6tVq5aef/553XXXXerfv7+uu+46SVLr1q1Vv359jRw5UsuWLVPbtm1djlu2bJm6deumOnXq5HvuLVu2aMOGDbrxxht14YUXau/evXr++efVrVs3/fLLLwXeXV6yZIkSExN16aWXavbs2UpNTdVTTz0lm82m7777zuUfLFlZWerZs6c6duyoOXPmaM2aNZo7d64aNmyou+66S1LO7Ms+ffpo8+bNuuuuu9S0aVN98MEHGjp0aKHfoy5dumjMmDF6+umndf/996tZs2aS5PxvfmbPnq2wsDBNnjxZu3bt0oIFCxQUFKSAgAAdPXpU06dP16ZNm7RkyRLVr19fU6dOdR47c+ZMPfTQQxo4cKBuv/12HT58WAsWLFCXLl3yvP9zbdiwQZLy/bsrDbt371ZgYKBLnM2bN1dYWJhsNpv69+/vs9gAwFvq1q2rjRs36qeffvL6Hrs33HCDGjdurFmzZsk0TV1zzTWaOHGi3nrrLd13330ufd966y1deeWVqlatWp7zBAUFqX///nrvvff0wgsvuMzeWbFihU6fPq0bb7xRUk5S7aWXXtJNN92kESNG6MSJE3r55ZfVs2dPbd68WXFxccV6L4y/8mL8VXHGXx999JEkaciQIW6Pq1SpkgYPHqwZM2bIZrOpe/fuqlu3rqSc3+cHH3wwz+/kuSIjI9WwYUPZbDaNGzeuwL4ox0zACxYvXmxKMrds2WL+/vvvZqVKlcwxY8Y4X+/atavZokUL5/Pk5GRTknn77be7nGfChAmmJHPdunUFXm/o0KGmJHP06NHOtuzsbPPqq682g4ODzcOHD5umaZp79uwxJZlVqlQxDx065HKOuLg4Myoqyvz777+dbd9//70ZEBBgDhkyxNnWp08f02KxmH/++aez7bfffjMrVapknvsnJMkMCAgwf/75Z5f24cOHm7Vr1zaPHDni0n7jjTeakZGRpsPhME3TNK+99lqX75M7kZGR5siRIwvsM3ToULNu3brO5ytWrDAlmf/9739d+g0YMMA0DMPctWuXy3sIDg52afv+++9NSeaCBQsKvO4XX3xhSjLr1KljpqWlOdvfeustU5L51FNPOdu6du1qSjIXLlzoco758+ebksz//e9/zraMjAwzPj7ejIiIcJ4392cbFhZm/vHHH86+33zzjSnJHDdunLMt9/t7tjfeeMOUZH711VfOtmnTppmSzL59+7r0vfvuu01J5vfff+9sq1u3rjl06NA87/2LL75wtp37czh8+LApyZw2bVqeeG666SbzggsuMLOyspxt27ZtMyWZixcvztP/bO7e38aNG01J5tKlS/ONMSMjw4yKijJbtmxpnjx50tnv448/NiWZU6dOdXkvksyHH37Y5Tpt27Y127Vr53z+7rvvmpLM+fPnO9uysrLMK664okjv5e23387zfczVtWtXs2vXrnneT8uWLc2MjAxn+0033WQahmH26tXL5fj4+HiXn8fevXvNwMBAc+bMmS79fvzxR7NSpUp52s/14IMPmpLMEydO5Ntny5YtRXrfhfXr2rWr2bRpU/Pw4cPm4cOHze3bt5tjxowxJZl9+vTJ0//iiy/O8/4BoKxavXq1GRgYaAYGBprx8fHmxIkTzVWrVrn8v980/x0buPt/6bmfv7mf+TfddFOevvHx8S6fbaZpmps3b87zuXru5/yqVatMSeZHH33kcmzv3r3NBg0aOJ+fOXPGPH36tEufo0ePmtHR0eZtt91WYNzuMP5i/MX4yzT79etnSjKPHj2a77HvvfeeKcl8+umnTdPM+Rk2adLElGTWrVvXHDZsmPnyyy+bqamp+Z7jyiuvNJs1a1ZgjCjfWM4Jr2vQoIFuvfVWvfjiizp48KDbPp9++qkkafz48S7t9957ryTpk08+KdK1Ro0a5fw6d5ZXRkaG1qxZ49Lv+uuvd5k5dvDgQSUnJ2vYsGGqXr26s71169bq0aOHM76srCytWbNG/fr1c5lV16hRI/Xq1cttTF27dlXz5s2dz03T1Lvvvqs+ffrINE0dOXLE+ejZs6eOHz/uXIpZtWpV/fHHH9qyZUu+77lq1ar65ptvXKrFFObTTz9VYGCgxowZ49J+7733yjRNffbZZy7t3bt3d9nQvHXr1qpSpYp2795dpOsNGTJElStXdj4fMGCAateu7fy+5goJCcmz7OHTTz9VTEyMy0ahQUFBGjNmjNLT0/Xll1+69O/Xr5/LXcIOHTqoY8eOLtc6++7rqVOndOTIEXXq1EmSXJbB5ho5cqTL89wNi8+N35uGDBmiv/76y2Upx7JlyxQWFqbrr7++wGPPfn+ZmZn6+++/1ahRI1WtWtXt+8v17bff6tChQ7r77rtd9pS4+uqr1bRpU7d/h3feeafL84SEBJffi5UrVyooKEgjRoxwtgUEBOT5nnrTkCFDXPY/6dixo0zT1G233ebSr2PHjjpw4IDOnDkjSXrvvfeUnZ2tgQMHuvxdxsTEqHHjxoUuq/n7779VqVKlUtt3bMeOHapVq5Zq1aqlZs2aacGCBbr66qvdLguvVq2ajhw5UipxAUBJ69GjhzZu3Ki+ffvq+++/1+OPP66ePXuqTp06510p79zPNUkaNGiQtm7d6lzqJUnLly9XSEiIrr322nzPdcUVV6hmzZpavny5s+3o0aP6/PPPNWjQIGdbYGCgc6Zadna2/vnnH505c0bt27cv8HO7MIy/PMf4q/j8bfx14sQJSXL5GzhX7mtpaWmScn6G33zzjXPW6ZIlSzR8+HDVrl1bo0ePdrsMlTEWSKKhRDz44IM6c+ZMvnuj7du3TwEBAWrUqJFLe0xMjKpWrep2H4pzBQQE5NnQ8eKLL5akPHsR1K9fP8/1JalJkyZ5ztusWTMdOXJEdrtdhw4d0smTJ/PEKcltm7trHT58WMeOHdOLL77o/Adw7iN3AJO7Ke6kSZMUERGhDh06qHHjxho5cqRsNpvL+R5//HH99NNPio2NVYcOHTR9+vRCk1v79u3TBRdckOdDJXea9rnf74suuijPOapVq+bcA6QwjRs3dnluGIYaNWqU5+dSp06dPJuV7tu3T40bN85TeSm/WM+9lpTze3D2tf755x+NHTtW0dHRCgsLU61atZw/p+PHjxcaf8OGDRUQEFCiZb979Oih2rVra9myZZJyBtVvvPGGrr322gIHA5J08uRJTZ061bnfXc2aNVWrVi0dO3bM7fvLVdDfQdOmTfN8r0NDQ/MsYz7392Lfvn2qXbt2niUM+f29eMO5v6+RkZGSpNjY2Dzt2dnZzu/Jb7/9JtM01bhx4zx/m9u3b/fqZtXeUK9ePX3++edas2aNvv76a6WkpOjjjz9WzZo18/Q1TbPQJQkAUJZceumleu+993T06FFt3rxZU6ZM0YkTJzRgwADnXrfFce64TcpZ4hkQEOBMhpmmqbffflu9evXKs0fS2SpVqqTrr79eH3zwgfMf3++9954yMzNdkmiS9Oqrr6p169YKDQ1VjRo1VKtWLX3yyScFfm4XhvGX5xh/FZ+/jb9yf165yTR33CXaIiMj9fjjj2vv3r3au3evXn75ZZfCTedijAX2REOJaNCggW655Ra9+OKLmjx5cr79Sut/QGffKSrta+WW2L7lllvy3ZegdevWknIGKjt37tTHH3+slStX6t1339Vzzz2nqVOnOktzDxw4UAkJCXr//fe1evVqPfHEE3rsscf03nvv5Ts7zlO5ZZ/PZZ5ThOB8ldbPZeDAgdqwYYPuu+8+xcXFKSIiQtnZ2brqqquKVJq+NH5PAwMDNXjwYC1atEjPPfecbDab/vrrr3wrNZ5t9OjRWrx4se655x7Fx8crMjJShmHoxhtvLNL78yRGf5RfXIX9HmdnZ8swDH322Wdu+xY2w6xGjRo6c+aMTpw4UehA2xvCw8OLXMTg6NGjbv+BAwBlXXBwsC699FJdeumluvjii5WYmKi3335b06ZNy/fz+twN2M/mbixywQUXKCEhQW+99Zbuv/9+bdq0Sfv379djjz1WaHw33nijXnjhBX322Wfq16+f3nrrLTVt2lRt2rRx9vnf//6nYcOGqV+/frrvvvsUFRWlwMBAzZ4922X2W0lh/PUvxl/F52/jr2bNmmnFihX64Ycf1KVLF7fH/vDDD5LksmrobHXr1tVtt92m/v37q0GDBlq2bJn++9//uvQ5evSo2xuYqDhIoqHEPPjgg/rf//7ndsBRt25dZWdn67fffnPZtDI1NVXHjh1zbvJYkOzsbO3evds5+0ySfv31V0nKU5nS3fUlaefOnXle27Fjh2rWrKnw8HCFhoYqNDRUu3btytPPXZs7tWrVUuXKlZWVlVWkfwCHh4dr0KBBGjRokDIyMnTddddp5syZmjJlinPKd+3atXX33Xfr7rvv1qFDh3TJJZdo5syZ+SbR6tatqzVr1uT5sNmxY4fzdW/67bffXJ6bpqldu3Y5k4UFqVu3rn744QdlZ2e73A3NL9ZzryXl/B7k/g4cPXpUa9eu1YwZM1w2NHV33NmvnX1neteuXcrOzi7096owhQ0GhwwZorlz5+qjjz7SZ599plq1aqlnz56Fnvedd97R0KFDNXfuXGfbqVOndOzYsQKPO/vv4IorrnB5befOncX6vahbt66++OILORwOl7uhRf17Kc07ew0bNpRpmqpfv77L/0eKqmnTppJyqkQV5Xe7tJw5c0YHDhxwW5kKAMqT9u3bS5Jz+5DcDf/P/fwrygqHcw0aNEh33323du7cqeXLl8tisahPnz6FHtelSxfVrl1by5cv12WXXaZ169bpgQcecOnzzjvvqEGDBnrvvfdcPvemTZvmcZxnY/zlHuOvwpWH8dc111yj2bNna+nSpW6TaFlZWXr99ddVrVo1t9U4z1atWjU1bNgwT8XZ3OuenRRHxcNyTpSYhg0b6pZbbtELL7yglJQUl9d69+4tSZo/f75L+7x58yTl7AlQFM8884zza9M09cwzzygoKEj/+c9/Cjyudu3aiouL06uvvuryQffTTz9p9erVzvgCAwPVvXt3rVixwmUPsl27duXZRyw/gYGBuv766/Xuu++6/R/x4cOHnV+fW/I7ODhYzZs3l2mayszMVFZWVp7p4VFRUbrgggvcrtnP1bt3b2VlZbl8v6Sc0uSGYXhtBluu3IpNud555x0dPHiwSNfp3bu3UlJSXPYTOXPmjBYsWKCIiAh17drVpf+KFStcyoFv3rxZ33zzjfNauXe4zp1Fd+7v3tmeffZZl+cLFiyQpPP+PuUOavIbXLVu3VqtW7fWSy+9pHfffVc33nijKlUq/F5HYGBgnve3YMGCAu+8Szn/+IiKitLChQtdfn8+++wzbd++vch/h2fr2bOnMjMztWjRImdbdnZ2nu9pfsLDwyXl/z3ypuuuu06BgYGaMWNGnu+faZp5/h7PFR8fLylnbxN/8ssvv+jUqVPq3Lmzr0MBAK/44osv3M6Gz90rK3dZXJUqVVSzZk199dVXLv2ee+45j695/fXXKzAwUG+88YbefvttXXPNNc7PqIIEBARowIAB+uijj/Taa6/pzJkzeZZyuhubfPPNN9q4caPHcZ6N8Zd7jL8KVx7GX507d1b37t21ePFiffzxx3mOe+CBB/Trr79q4sSJztmY33//vdv9zfbt26dffvklz5Lb48eP6/fff2eMVcExEw0l6oEHHtBrr72mnTt3qkWLFs72Nm3aaOjQoXrxxRd17Ngxde3aVZs3b9arr76qfv366fLLLy/03KGhoVq5cqWGDh2qjh076rPPPtMnn3yi+++/P8++Ae488cQT6tWrl+Lj4zV8+HCdPHlSCxYsUGRkpKZPn+7sN336dK1evVpWq1V33XWXMxnVsmVLJScnF+n78Oijj+qLL75Qx44dNWLECDVv3lz//POPtm3bpjVr1uiff/6RJF155ZWKiYmR1WpVdHS0tm/frmeeeUZXX321KleurGPHjunCCy/UgAED1KZNG0VERGjNmjXasmWLy12wc/Xp00eXX365HnjgAe3du1dt2rTR6tWr9cEHH+iee+5xKSLgDdWrV9dll12mxMREpaamav78+WrUqJHLZqf5ueOOO/TCCy9o2LBh2rp1q+rVq6d33nlHNptN8+fPz7NsrlGjRrrssst011136fTp05o/f75q1KihiRMnSsoZUHfp0kWPP/64MjMzVadOHa1evVp79uzJN4Y9e/aob9++uuqqq7Rx40b973//0+DBg8/7rlNYWJiaN2+u5cuX6+KLL1b16tXVsmVLtWzZ0tlnyJAhmjBhgiQVaSmBlHPn7bXXXlNkZKSaN2+ujRs3as2aNapRo0aBxwUFBemxxx5TYmKiunbtqptuuslZYr1evXrFKt3dr18/dejQQffee6927dqlpk2b6sMPP3T+jhd2pzMuLk6BgYF67LHHdPz4cYWEhOiKK65QVFSUx7EUpmHDhvrvf/+rKVOmaO/everXr58qV66sPXv26P3339cdd9zh/Fm406BBA7Vs2VJr1qzJs4muL33++eeyWCzq0aOHr0MBAK8YPXq0HA6H+vfvr6ZNmyojI0MbNmzQ8uXLVa9ePZdN8m+//XY9+uijuv3229W+fXt99dVXzpUKnoiKitLll1+uefPm6cSJE3kSYQUZNGiQFixYoGnTpqlVq1Yuqy6knM/t9957T/3799fVV1+tPXv2aOHChWrevLnS09M9jjUX4y/3GH9VnPHX0qVL9Z///EfXXnutBg8erISEBJ0+fVrvvfee1q9fr0GDBjmLCEg5Y6Zp06apb9++6tSpkyIiIrR792698sorOn36tMu/CSVpzZo1Mk2zwAIjqABKowQoyr/FixebkswtW7bkeS23NHOLFi1c2jMzM80ZM2aY9evXN4OCgszY2FhzypQp5qlTpwq93tChQ83w8HDz999/N6+88krTYrGY0dHR5rRp01xKVOeW4X7iiSfcnmfNmjWm1Wo1w8LCzCpVqph9+vQxf/nllzz91q5da7Zt29YMDg42GzZsaL700kvmvffea4aGhrr0k2SOHDnS7bVSU1PNkSNHmrGxsWZQUJAZExNj/uc//zFffPFFZ58XXnjB7NKli1mjRg0zJCTEbNiwoXnfffeZx48fN03TNE+fPm3ed999Zps2bczKlSub4eHhZps2bcznnnsuz/fn7FLSpmmaJ06cMMeNG2decMEFZlBQkNm4cWPziSeeMLOzs4v0Hs4tKe5ObsnrN954w5wyZYoZFRVlhoWFmVdffbW5b98+l75du3bN8ztx9vcqMTHRrFmzphkcHGy2atUqT2nus3+2c+fONWNjY82QkBAzISHBpRS6aZrmH3/8Yfbv39+sWrWqGRkZad5www3mX3/9lW+5+19++cUcMGCAWblyZbNatWrmqFGjXEqQu/t+FKXEumma5oYNG8x27dqZwcHBbsutHzx40AwMDDQvvvhit98bd44ePer8fkVERJg9e/Y0d+zYUaQYTdM0ly9fbrZt29YMCQkxq1evbt58880uZetz30t4eHiea+d+z852+PBhc/DgwWblypXNyMhIc9iwYabNZjMlmW+++Wah72fRokVmgwYNzMDAQJd48yux/vbbb7scn9//j3JjPXz4sEv7u+++a1522WVmeHi4GR4ebjZt2tQcOXKkuXPnzkJjnTdvnhkREeG2zL1pmuaWLVuKVFq+sH4F/b2cq2PHjuYtt9xSpL4AUBZ89tln5m233WY2bdrUjIiIMIODg81GjRqZo0ePNlNTU136OhwOc/jw4WZkZKRZuXJlc+DAgeahQ4fy/cw/9zPhbIsWLTIlmZUrV84zDjBN95/zpmma2dnZZmxsrCnJ/O9//+v29VmzZpl169Y1Q0JCzLZt25off/yx2/O5Gyuci/EX4y/TZPyV68SJE+b06dPNFi1amGFhYWblypVNq9VqLlmyJM+/e3bv3m1OnTrV7NSpkxkVFWVWqlTJrFWrlnn11Veb69aty3PuQYMGmZdddlmh8aF8M0zTyzuFA6Vg2LBheuedd87rbt356tevn37++ecC93aoaNavX6/LL79cb7/9tgYMGODrcMqkI0eOqHbt2po6daoeeughX4fjNStWrFD//v319ddfF7oPRVly/PhxNWjQQI8//riGDx/u63CUnJysSy65RNu2bVNcXJyvwwEAlALGX+eP8VfZ4ovxV0pKiurXr68333yTmWgVHHuiAUVw8uRJl+e//fabPv30U3Xr1s03AaHcWrJkibKysnTrrbf6OpRiO/fvJSsrSwsWLFCVKlV0ySWX+CiqkhEZGamJEyfqiSee8GolruJ69NFHNWDAABJoAAB4gPFX2eKL8df8+fPVqlUrEmhgTzSgKBo0aKBhw4apQYMG2rdvn55//nkFBwc7930Azte6dev0yy+/aObMmerXr995V6LypdGjR+vkyZOKj4937kOxYcMGzZo1y7mRa3kyadIkTZo0yddhSJLefPNNX4cAAECZwfir7Crt8dejjz5aateCfyOJBhTBVVddpTfeeEMpKSkKCQlRfHy8Zs2apcaNG/s6NJQTDz/8sDZs2CCr1eqsRlVWXXHFFZo7d64+/vhjnTp1So0aNdKCBQs0atQoX4cGAADgxPgLgKfYEw0AAAAAAAAoBHuiAQAAAAAAAIUgiQYAAAAAAAAUosLtiZadna2//vpLlStXlmEYvg4HAACUEaZp6sSJE7rgggsUEMB9SH/EOA8AABRHUcd5FS6J9tdffyk2NtbXYQAAgDLqwIEDuvDCC30dBtxgnAcAAM5HYeO8CpdEq1y5sqScb0yVKlV8HA0AACgr0tLSFBsb6xxLwP8wzgMAAMVR1HFehUui5U7tr1KlCoMrAADgMZYJ+i/GeQAA4HwUNs5jQw8AAAAAAACgECTRAAAAAAAAgEKQRAMAAAAAAAAKUeH2RAMAAAAAADhfpmnqzJkzysrK8nUoKERgYKAqVap03nvbkkQDAAAAAADwQEZGhg4ePCiHw+HrUFBEFotFtWvXVnBwcLHPQRINAAAAXvfVV1/piSee0NatW3Xw4EG9//776tevX4HHrF+/XuPHj9fPP/+s2NhYPfjggxo2bFipxAsAQFFlZ2drz549CgwM1AUXXKDg4GCqd/sx0zSVkZGhw4cPa8+ePWrcuLECAoq3uxlJNAAAAHid3W5XmzZtdNttt+m6664rtP+ePXt09dVX684779SyZcu0du1a3X777apdu7Z69uxZChEDAFA0GRkZys7OVmxsrCwWi6/DQRGEhYUpKChI+/btU0ZGhkJDQ4t1HpJoAAAA8LpevXqpV69eRe6/cOFC1a9fX3PnzpUkNWvWTF9//bWefPJJkmgAAL9U3NlM8A1v/Lz4iQMAAMDnNm7cqO7du7u09ezZUxs3bsz3mNOnTystLc3lAQAAUFJIogEAAMDnUlJSFB0d7dIWHR2ttLQ0nTx50u0xs2fPVmRkpPMRGxtbGqECAIAKiiQaAAAAyqQpU6bo+PHjzseBAwd8HRIAAH6tW7duuueee3wdhurVq6f58+d7vW9JY080AAAA+FxMTIxSU1Nd2lJTU1WlShWFhYW5PSYkJEQhISGlER4AAPCiLVu2KDw83NdheIyZaAAAAPC5+Ph4rV271qXt888/V3x8vI8iAgAA3paRkSFJqlWrVpmsbEoSDQAAAF6Xnp6u5ORkJScnS5L27Nmj5ORk7d+/X1LOUswhQ4Y4+995553avXu3Jk6cqB07dui5557TW2+9pXHjxvkifAAAPGKapuwZdp88TNMsdtxHjx7VkCFDVK1aNVksFvXq1Uu//fab8z3VqlVL77zzjrN/XFycateu7Xz+9ddfKyQkRA6Hw+35hw0bpn79+mnmzJm64IIL1KRJE0muSzRN09T06dN10UUXKSQkRBdccIHGjBmTb8wvvfSSqlatmufmW2lgOScAAAC87ttvv9Xll1/ufD5+/HhJ0tChQ7VkyRIdPHjQmVCTpPr16+uTTz7RuHHj9NRTT+nCCy/USy+9pJ49e5Z67AAAeMqR6VDE7AifXDt9SrrCg4u3NHLYsGH67bff9OGHH6pKlSqaNGmSevfurV9++UVBQUHq0qWL1q9frwEDBujo0aPavn27wsLCtGPHDjVt2lRffvmlLr300gJnla1du1ZVqlTR559/7vb1d999V08++aTefPNNtWjRQikpKfr+++/d9n388cf1+OOPa/Xq1erQoUOx3vP5IIkGAAAAr+vWrVuBd8aXLFni9pjvvvuuBKMCAAC5cpNnNptNnTt3liQtW7ZMsbGxWrFihW644QZ169ZNL7zwgiTpq6++Utu2bRUTE6P169eradOmWr9+vbp27VrgdcLDw/XSSy8pODjY7ev79+9XTEyMunfvrqCgIF100UVuE2STJk3Sa6+9pi+//FItWrQ4z3dfPCTRAAAAAAAAzoMlyKL0Kek+u3ZxbN++XZUqVVLHjh2dbTVq1FCTJk20fft2SVLXrl01duxYHT58WF9++aW6devmTKINHz5cGzZs0MSJEwu8TqtWrfJNoEnSDTfcoPnz56tBgwa66qqr1Lt3b/Xp00eVKv2bspo7d67sdru+/fZbNWjQoFjv1xt8uifaV199pT59+uiCCy6QYRhasWJFocesX79el1xyiUJCQtSoUSO3dzEBAAAAAABKi2EYCg8O98nDMIwSe1+tWrVS9erV9eWXXzqTaN26ddOXX36pLVu2KDMz0zmLLT+FVeGMjY3Vzp079dxzzyksLEx33323unTposzMTGefhIQEZWVl6a233vLK+younybR7Ha72rRpo2effbZI/ffs2aOrr75al19+uZKTk3XPPffo9ttv16pVq0o4UgAAAAAAgPKjWbNmOnPmjL755htn299//62dO3eqefPmknKSgwkJCfrggw/0888/67LLLlPr1q11+vRpvfDCC2rfvn2hSbKiCAsLU58+ffT0009r/fr12rhxo3788Ufn6x06dNBnn32mWbNmac6cOed9veLy6XLOXr16qVevXkXuv3DhQtWvX19z586VlPMD//rrr/Xkk0/6z6azpinlU5WiSCwWqQSzyAAAACim4ozzGNsBAPxU48aNde2112rEiBF64YUXVLlyZU2ePFl16tTRtdde6+zXrVs33XvvvWrfvr0iInKKJ3Tp0kXLli3Tfffdd95xLFmyRFlZWerYsaMsFov+97//KSwsTHXr1nXp17lzZ3366afq1auXKlWqpHvuuee8r+0pn85E89TGjRvVvXt3l7aePXtq48aN+R5z+vRppaWluTxKlMMhRUQU/5GQkDNAAwAAgN8wTVP2Y4cZ2wEAypXFixerXbt2uuaaaxQfHy/TNPXpp58qKCjI2adr167KyspSt27dnG3dunXL01ZcVatW1aJFi2S1WtW6dWutWbNGH330kWrUqJGn72WXXaZPPvlEDz74oBYsWHDe1/aUYRZUNqkUGYah999/X/369cu3z8UXX6zExERNmTLF2fbpp5/q6quvlsPhUFhYWJ5jpk+frhkzZuRpP378uKpUqeKV2F3Y7TkDpvORni55YTokAADwnrS0NEVGRpbcGALnrSR/RvYMu6JmRMg+qxgHM7YDgHLl1KlT2rNnj+rXr6/Q0FBfh4MiKujnVtQxRLmvzjllyhSNHz/e+TwtLU2xsbEld0GLJWeg5Cm7XYqO9n48AAAA8ApHkBR+/7/PD01IVXhwPskxxnYAAJQ7ZSqJFhMTo9TUVJe21NRUValSxe0sNEkKCQlRSEhIaYSXwzC40wgAAFDOWIIsSr8/XfZMu6Ln/P/kWHi4lF8SDQAAlDtlKokWHx+vTz/91KXt888/V3x8vI8iAgAAQEVgGEb+s84AAECF4NPCAunp6UpOTlZycrIkac+ePUpOTtb+/fsl5SzFHDJkiLP/nXfeqd27d2vixInasWOHnnvuOb311lsaN26cL8IHAAAAAABABeHTJNq3336rtm3bqm3btpKk8ePHq23btpo6daok6eDBg86EmiTVr19fn3zyiT7//HO1adNGc+fO1UsvvaSePXv6JH4AAAAAAABUDD5dztmtWzcVVBx0yZIlbo/57rvvSjAqAAAAAAAAwJVPZ6IBAAAAAAAAZQFJNAAAAAAAAKAQJNEAAAAAAACAQpBE80cF7BMHAACAMsZuL9qDMSAAoIR169ZN99xzT4F9DMPQihUrinzO9evXyzAMHTt27Lxik3L2xq9atarX+3qLTwsLIB8JCdK2bZJh+DoSAAAA5MOeaXfbbgmyyGUUFx1dtBNarVJSEmNAAIBPHTx4UNWqVfPJtQcNGqTevXv75NpFQRLNi0zTlCPTUWAfS5BFhruBkcUixcVJyck5D4dDCg8viTABAADgBdFz3CfHrLFWJQ37SobVKtlsRT+hzcYYEADgczExMT65bmZmpsLCwhQWFuaT6xcFyzm9yJHpUMTsiAIfCYsTZLqbqm8YOXceAQAA4LcsQRZZY60F9rEdsMlx5mTO2C49vfBHamopRQ8AKDGmWfTl+95+eLgdQHZ2tiZOnKjq1asrJiZG06dPd3n93OWcGzZsUFxcnEJDQ9W+fXutWLFChmEoOTnZ5bitW7eqffv2slgs6ty5s3bu3JlvDHv37pVhGFq+fLm6du2q0NBQLVu2LM8Sze+//16XX365KleurCpVqqhdu3b69ttv3Z7z8OHDat++vfr376/Tp0979D0pKmailTLbAZscmQ6FB7u5w8jUfQAAAL9mGIaSEpPcrj6wZ9pdZ6cZBrPKAKCicDikiAjfXDs93aPPm1dffVXjx4/XN998o40bN2rYsGGyWq3q0aNHnr5paWnq06ePevfurddff1379u3Ld0+1Bx54QHPnzlWtWrV055136rbbbpOtkBnZkydP1ty5c9W2bVuFhoZq1apVLq/ffPPNatu2rZ5//nkFBgYqOTlZQUFBec5z4MAB9ejRQ506ddLLL7+swMDAIn8/PEESzYssQRalT0l3+1qeQRUAAADKJMMw3N8QBQCgDGjdurWmTZsmSWrcuLGeeeYZrV271m0S7fXXX5dhGFq0aJFCQ0PVvHlz/fnnnxoxYkSevjNnzlTXrl0l5STHrr76ap06dUqhoaH5xnLPPffouuuuy/f1/fv367777lPTpk2d8Z5r586d6tGjh/r376/58+e730LLS0iieREDKgAAAAAAKiCLJWdGmK+u7YHWrVu7PK9du7YOHTrktu/OnTvVunVrl0RYhw4dCj1v7dq1JUmHDh3SRRddlG8s7du3LzDW8ePH6/bbb9drr72m7t2764YbblDDhg2dr588eVIJCQkaPHiw5s+fX+C5vIE90QAAAAAAAM5H7hJ+Xzw8nHl17nJIwzCUnZ193t+Cs8+bOxussPOGF7IMdfr06fr555919dVXa926dWrevLnef/995+shISHq3r27Pv74Y/3555/nEX3RkEQDAAAAAABAHk2aNNGPP/7oslH/li1bSjWGiy++WOPGjdPq1at13XXXafHixc7XAgIC9Nprr6ldu3a6/PLL9ddff5VoLCTRAAAAAAAAkMfgwYOVnZ2tO+64Q9u3b9eqVas0Z84cSSrRvceknKWao0aN0vr167Vv3z7ZbDZt2bJFzZo1c+kXGBioZcuWqU2bNrriiiuUkpJSYjGRRAMAAAAAAEAeVapU0UcffaTk5GTFxcXpgQce0NSpUyWpwIIB3hAYGKi///5bQ4YM0cUXX6yBAweqV69emjFjRp6+lSpV0htvvKEWLVroiiuuyHePt/NlmKZplsiZ/VRaWpoiIyN1/PhxValSpdSua8+wK2J2Trnb9Cnp7gsQ2O3/lsT1sEQtAAAoWb4aQ6DofP0zKtJ4z+2BjAEBoCw5deqU9uzZo/r165d4IskfLVu2TImJiTp+/LjCwsJ8HU6RFfRzK+oYguqc/qpi5TYBAAAg5STULBaPN4kGAKCkLF26VA0aNFCdOnX0/fffa9KkSRo4cGCZSqB5C8s5/VVCAok0AACAiiY6mnEgAMCvpKSk6JZbblGzZs00btw43XDDDXrxxRd9HZZPMBPNn1gsUlyclJyc83A4mM4PAABQBtkz7fm+ZgmyuG7GbLFIVqtks+U8t9kYBwIA/MbEiRM1ceJEX4fhF0ii+cC5gyrnQMowpKQkqXJlH0UGAAAAb4ieE53va9ZYq5ISk/5NpOWOAQ8fzpmJBgAA/BJJNB84d1DlMpBi/wsAAIAyyRJkkTXWKtsBW4H9bAdscmQ6XAsPGAYzzwCgjKlgdRrLPG/8vEiilZKCBlVuB1IAAAAoUwzDUFJikhyZDrev2zPtBc5QAwCUDUFBQZIkh8NRITfXL6scjpzP59yfX3GQRCsl7gZVDKQAAADKF8MwuDEKAOVcYGCgqlatqkOHDkmSLJZz9rqEXzFNUw6HQ4cOHVLVqlUVGBhY7HORRCtFDKoAAAAAACj7YmJiJMmZSIP/q1q1qvPnVlwk0QAAAAAAADxgGIZq166tqKgoZWZm+jocFCIoKOi8ZqDlIokGAAAAAABQDIGBgV5JzqBsCPB1AAAAAAAAAIC/I4kGAAAAAAAAFIIkGgAAAAAAAFAIkmj+zDR9HQEAAAAAAABEEs2/JSSQSAMAACiH7Jl2mYzzAAAoU0ii+RuLRYqLy/k6OVlyOHwZDQAAAEpA9JxoJSxOIJEGAEAZQhLNTzjvRhqGlJTk63AAAADgZZYgi6yxVudz2wGbHJncMAUAoKwgieYnXO5GGoavwwEAAICXGYahpMQkpU5I9XUoAACgGEii+RB3IwEAACoWwzAUHhTu6zAAAEAxkETzIe5GAgAAAAAAlA0k0XyMu5EAAAAAAAD+jyQaAAAAAAAAUAiSaAAAAAAAAEAhSKIBAAAAAAAAhajk6wAAAAAAnMNud99usUiGUbqxAAAASSTRAAAAAP8THe2+3WqVkpJIpAEA4AMs5wQAAAD8gcWSkyQriM0mORylEw8AAHDBTDQAAADAR+yZdlmCLDIMI2d2WVKS+ySZ3Z7/7DQAAFAqmIkGAAAA+Ej0nGglLE6QaZo5DYYhhYe7fwAAAJ8iiQYAAACUIkuQRdbYf5dt2g7Y5MhkiSYAAP6OJJqfMWX6OgQAAACUIMMwlJSYpNQJqb4OBQAAeIAkmp9xmc4PAACAcskwDIUHsUQTAICyhCSaH7AEWRQXEydJSk5JZjo/AAAAAACAnyGJ5gdyp/QDAAAAAADAP5FE8xOGDF+HAAAAAAAAgHyQRAMAAAAAAAAKQRINAAAAAAAAKARJNH9nt0tU6wQAAAAAAPApkmj+LjpaSkggkQYAAAAAAOBDJNH8kcUiWa3/PrfZJIfDd/EAAAAAAABUcJV8HQDcMAwpKUk6fDhnJhoAAADKNXumPU+bJcgiw6CCOwAA/oIkmr8yDCk83NdRAAAAoBREz8l749Qaa1VSYhKJNAAA/ATLOQEAAAAfsARZZI215vu67YBNjky29AAAwF8wE80POafzZ9iVOxfNNE1xDxIAAKD8MAxDSYlJeRJl9ky725lpAADAt0ii+aHcQZMlQ8rdHaPHaz30+Z0bmM4PAABQjhiGofBgtvAAAKAsYDmnnyhsOv/GPzYxnR8AAAAAAMBHmInmJ9xO57fbpVlM5QcAAAAAAPA1kmh+JM90/kzfxQIAAAAAAIB/sZwTAAAAKEtM09cRAABQIZFEKyMMxkoAAACQpIQEEmkAAPgASbQyImmxGCwBAABUVBaLFBeX83VysuSg4BQAAKWNJJo/s1iU1aa1JKltihgsAQAAVFSGISUl+ToKAAAqNJJo/swwdGrdal9HAQAAAB+xZ9plz8h5sCYBAADfojqnvzMMX0cAAAAAH4meE+38+j9RnbTGh7EAAFDRMRMNAAAA8COWIIussdY87Rv/2OSDaAAAQC5mogEAAAB+xDAMJSUmyZGZsx+uPdPuMiMNAAD4Bkk0AAAAwM8YhqHw4HBfhwEAAM7Cck4AAAAAAACgECTRAAAAAAAAgEKQRAMAAAAAAAAKwZ5oAAAAQFljt7s+t1gkw/BNLAAAVBDMRAMAAADKmuhoKSLi30dCgmSavo4KAIByjSQaAAAAUAY4gqSszvHuX7TZJIejdAMCAKCCIYkGAACAEvPss8+qXr16Cg0NVceOHbV58+YC+8+fP19NmjRRWFiYYmNjNW7cOJ06daqUovVzhnRq3WopPf3fR2qqr6MCAKDCYE80AAAAlIjly5dr/PjxWrhwoTp27Kj58+erZ8+e2rlzp6KiovL0f/311zV58mS98sor6ty5s3799VcNGzZMhmFo3rx5PngHfsgwpPBwX0cBAECFxEw0AAAAlIh58+ZpxIgRSkxMVPPmzbVw4UJZLBa98sorbvtv2LBBVqtVgwcPVr169XTllVfqpptuKnT2WkViin3PAADwFZJoAAAA8LqMjAxt3bpV3bt3d7YFBASoe/fu2rhxo9tjOnfurK1btzqTZrt379ann36q3r17u+1/+vRppaWluTzKu4TFCTIpIAAAgE+QRAMAAIDXHTlyRFlZWYqOjnZpj46OVkpKittjBg8erIcffliXXXaZgoKC1LBhQ3Xr1k3333+/2/6zZ89WZGSk8xEbG+v19+EPLEEWxcXESZKSU5LlyKSAAAAAvkASDQAAAH5h/fr1mjVrlp577jlt27ZN7733nj755BM98sgjbvtPmTJFx48fdz4OHDhQyhGXDsMwlJSY5OswAACo8CgsAAAAAK+rWbOmAgMDlXpO9cjU1FTFxMS4Peahhx7Srbfeqttvv12S1KpVK9ntdt1xxx164IEHFBDgev83JCREISEhJfMG/Iwhw9chAABQ4TETDQAAAF4XHBysdu3aae3atc627OxsrV27VvHx8W6PcTgceRJlgYGBksQ+YAAAwOeYiVaG2DPtUoY9T7slyCLD4O4kAADwL+PHj9fQoUPVvn17dejQQfPnz5fdbldiYqIkaciQIapTp45mz54tSerTp4/mzZuntm3bqmPHjtq1a5ceeugh9enTx5lMAwAA8BWSaGVI/acayBGct90aa1VSYhKJNAAA4FcGDRqkw4cPa+rUqUpJSVFcXJxWrlzpLDawf/9+l5lnDz74oAzD0IMPPqg///xTtWrVUp8+fTRz5kxfvYWyxZ73ZmseFovEmBEAgGIxzAo2Nz4tLU2RkZE6fvy4qlSp4utwCmWmp8uoXFmSFDVBsp+VRHMESbnbY6RPSVd4cHjpBwgAQAVR1sYQFVF5/hnZM+yKmB0h6Zxxn90uRUQU/URWq5SURCINAICzFHUMwUw0P3f27LJDc1xfy4jvoJArN4t9ZgEAACooiyUnMWazFa2/zSY5HFI4N18BAPAUhQX8Xe7AyI3gjZtlySzleAAAAOA/DCNnZll6esGPc6qkAgAAz/k8ifbss8+qXr16Cg0NVceOHbV58+YC+8+fP19NmjRRWFiYYmNjNW7cOJ06daqUovUBdwMjBkEAAADIZRg5M8sKewAAgPPi0yTa8uXLNX78eE2bNk3btm1TmzZt1LNnTx06dMht/9dff12TJ0/WtGnTtH37dr388stavny57r///lKOvJS5GxgBAACgQrJn2lXBtjUGAMAv+DSJNm/ePI0YMUKJiYlq3ry5Fi5cKIvFoldeecVt/w0bNshqtWrw4MGqV6+errzySt10002Fzl4DAAAAyovoOdFKWJxAIg0AgFLmsyRaRkaGtm7dqu7du/8bTECAunfvro0bN7o9pnPnztq6daszabZ79259+umn6t27d77XOX36tNLS0lweAAAAQFliCbLIGvvvPrm2AzY5Mh0+jAgAgIrHZ9U5jxw5oqysLEVHR7u0R0dHa8eOHW6PGTx4sI4cOaLLLrtMpmnqzJkzuvPOOwtczjl79mzNmDHDq7EDAAAApckwDCUlJumw47Ci50QXfgAAAPA6nxcW8MT69es1a9YsPffcc9q2bZvee+89ffLJJ3rkkUfyPWbKlCk6fvy483HgwIFSjBgAAADwDsMwFB7E3rgAAPiKz2ai1axZU4GBgUo9p9JkamqqYmJi3B7z0EMP6dZbb9Xtt98uSWrVqpXsdrvuuOMOPfDAAwoIyJsTDAkJUUhIiPffAAAAAAAAACoMn81ECw4OVrt27bR27VpnW3Z2ttauXav4+Hi3xzgcjjyJssDAQEliY1UAAAAAAACUGJ/NRJOk8ePHa+jQoWrfvr06dOig+fPny263KzExUZI0ZMgQ1alTR7Nnz5Yk9enTR/PmzVPbtm3VsWNH7dq1Sw899JD69OnjTKYBAAAAKAA3nwEAKBafJtEGDRqkw4cPa+rUqUpJSVFcXJxWrlzpLDawf/9+l5lnDz74oAzD0IMPPqg///xTtWrVUp8+fTRz5kxfvQW/YYrBEAAAAIogIUHatk0yDF9HAgBAmWKYFWwdZFpamiIjI3X8+HFVqVLF1+EUj90uRURIksLvlxzBUlxMnLbdsU0GgyEAAEpEuRhDlHMV4Wdkz7ArYnbOODB9SrrCg4tYaMA0pUsukZKTc56np0vhFCkAAEAq+hiiTFXnRF6to1tJkpJTkuXIdPg4GgAAAPglw5CSknwdBQAAZRpJtDLu81s/93UIAAAAKAtYsQAAwHkhiVbGGWIwBAAAAAAAUNJ8WlgAAAAAQPHYM+2SJEuQhX1xAQAoBcxEAwAAAMqg6DnRipgdoYTFCapgtcIAAPAJkmgAAABAGWEJssgaa3Vpsx2wUWAKAIBSwHJOAAAAoIwwDENJiUlyZDpkz7Qrek60r0MCAKDCIIkGAAAAlCGGYSg8ONzXYQAAUOGwnBMAAAAAAAAoBDPRAAAAgIrGbnd9brFIVPgEAKBAzEQDAAAAKproaCki4t9HQoJEhU8AAApEEg0AAACoCCwWyWp1/5rNJjmo8AkAQEFYzlmO2DPtBb5uCbLIYJo+AABAxWQYUlKSa7LMbs+ZlQYAAApFEq0cKazEuTXWqqTEJBJpAAAAFZVhSOFU9gQAoDhYzlnGWYIsssbmMy3/HLYDNjkymaYPAAAAAADgKWailXGGYSgpManA5Jg9017oLDUAAACUXYVt63EutvkAAMBzJNHKAcMwFB7MtHwAAICKytMbps5tPkooHgAAyiOWcwIAAABlkCfbepyLbT4AAPAcM9EAAACAMqgo23qci20+AAAoPpJoAAAAQBnFth4AAJQelnMCAAAAAAAAhSCJBgAAAAAAABSCJBoAAAAAAABQCJJoAAAAAAAAQCFIogEAAAAAAACFIIkGAAAAAAAAFKKSrwNA6bJn2vO0WYIsMgzDB9EAAAAAAACUDSTRKpjoOdF52qyxViUlJpFIAwAAAAAAyAfLOSsAS5BF1lhrvq/bDtjkyHSUYkQAAADwNXumXfaMf1cpmKbpw2gAAPB/zESrAAzDUFJiUp5EmT3T7nZmGgAAAMq/6DnRsmRIuWm0Hq/10Od3bmB1AgAA+WAmWgVhGIbCg8NdH0Hhvg4LAAAApaigFQob/9jE6gQAAArATDQAAACggsizQsFul2axMgEAgKIgiQYAAABUILkrFCRJmb6NBQCAsoTlnAAAAAAUniGJ4gIAAOSLJBoAAAAAHZojhV5xJYk0AADyQRKtrLPbGegAAACgeCwWZXWOdz4N3LBRclBcAAAAd0iilXXR0VJCAok0AAAAeM4wdGrdakVN8HUgAAD4P5JoZZHFIlnPKk1us3HHEAAAAMVjGLIH+zoIAAD8H0m0ssgwpKQkKTXV15EAAAAAAABUCCTRyirDkMLDfR0FAAAAAABAhUASDZIke6ZdJvuqAQAAVHiMCQEAcI8kGiRJ0XOilbA4gUETAABABdfjtR6MCQEAcIMkWgVmCbLIGvtvgQLbAZscmRQoAAAAqEgsQRbFX9jJ+XzjH5sYEwIA4AZJtArMMAwlJSYpdQIFCgAAACoqwzD0+a2f+zoMAAD8Hkm0Cs4wDIUHUaAAAACgIjMMw9chAADg9yr5OgAAAAAA/iM8Q5LdLmUW0tFiyakYDwBABcFMNAAAAABOh+ZI4dWjpYiIgh8JCRIFCAAAFYjHSbSuXbtq6dKlOnnyZEnEg+JiAAMAAIDisliU1Tnes2NsNslBAQIAQMXhcRKtbdu2mjBhgmJiYjRixAht2rSpJOKCp7gTCAAAgOIyDJ1at1rh90vh90v2f1Kl9HT3j1SKUgEAKiaPk2jz58/XX3/9pcWLF+vQoUPq0qWLmjdvrjlz5iiVD9TSZbFIcXE5XycncycQAAAAxWcYcgRLjmBJ4eEFPwAAqICKtSdapUqVdN111+mDDz7QH3/8ocGDB+uhhx5SbGys+vXrp3Xr1nk7TrhjGFJSkq+jAAAAAAAAKPfOq7DA5s2bNW3aNM2dO1dRUVGaMmWKatasqWuuuUYTJkzwVowoCBWRAAAAAAAASlwlTw84dOiQXnvtNS1evFi//fab+vTpozfeeEM9e/aU8f8TOsOGDdNVV12lOXPmeD1gAAAAAAAAoLR5nES78MIL1bBhQ912220aNmyYatWqladP69atdemll3olQAAAAAClyxQFqwAAOJfHSbS1a9cqISGhwD5VqlTRF198UeygAAAAAPhOwuIEbbtjm3OlCQAAKMaeaNOmTdOxY8fytKelpemKK67wRkwAAAAASpklyKK4mDhJUnJKshyZVH4HAOBsHifRvvzyS2VkZORpP3XqlJKoFAkAAACUSYZhKCmR8TwAAPkp8nLOH374QZJkmqZ++eUXpaSkOF/LysrSypUrVadOHe9HCAAAAKBUGPJw+abdLlksVIwHAFQIRU6ixcXFyTAMGYbhdtlmWFiYFixY4NXgAAAAAPix6GjJapWSkkikAQDKvSIn0fbs2SPTNNWgQQNt3rzZpSpncHCwoqKiFBgYWCJBAgAAAPATFktO4sxmy3lus0kOhxQe7tu4AAAoYUVOotWtW1eSlJ2dXWLBAAAAAPBzhpEz8+zw4ZyZaAAAVBBFSqJ9+OGH6tWrl4KCgvThhx8W2Ldv375eCQwAAACAnzIMZp4BACqcIiXR+vXrp5SUFEVFRalfv3759jMMQ1lZWd6KDQAAAAAAAPALRUqinb2Ek+WcAAAAAAAAqGgCfB0AAAAAAAAA4O+KNBPt6aefLvIJx4wZU+xgAAAAAAAAAH9UpCTak08+WaSTGYZBEg0AAAAoB+yZ9nxfswRZZJRiLAAA+IMiJdH27NlT0nEAAAAA8CPRc6Lzfc0aa1XSwJUk0gAAFQp7ogEAAACQlDPDzBprLbSf7YBNjkzHvw2mWYJRAQDgH4o0E238+PF65JFHFB4ervHjxxfYd968eV4JDL5hz7TnTM83uK8IAABQ0RiGoaTEJNcE2VnsmXb3M9QSEqRt2yTGkACAcqxISbTvvvtOmZmZzq/zQ+Kl7IueE50zPT8xiZ8nAAAVzLRp03Tbbbepbt26vg4FPmQYhsKDwwvvaLFIcXFScnLOw+GQwotwHAAAZVSRkmhffPGF269RPuRO27cdsEn6d3p+kQZPAACg3Pjggw80c+ZMde3aVcOHD9f111+vkJAQX4cFf2UYUlKSVLmyryMBAKBUnNeeaAcOHNCBAwe8FQvOVzH3osidtp86IdXLAQEAgLIkOTlZW7ZsUYsWLTR27FjFxMTorrvu0pYtW3wdGvwVKxcAABWIx0m0M2fO6KGHHlJkZKTq1aunevXqKTIyUg8++KBzySd8JCHhvBJp4UHMPAMAoKJr27atnn76af311196+eWX9ccff8hqtap169Z66qmndPz4cV+HCAAA4BMeJ9FGjx6tF198UY8//ri+++47fffdd3r88cf18ssva8yYMSURIwqSuxeF9O9eFAAAAOfJNE1lZmYqIyNDpmmqWrVqeuaZZxQbG6vly5f7OjwAAIBSV6Q90c72+uuv680331SvXr2cba1bt1ZsbKxuuukmPf/8814NEIVgLwoAAOBFW7du1eLFi/XGG28oJCREQ4YM0bPPPqtGjRpJkhYsWKAxY8Zo0KBBPo4UAACgdHk8Ey0kJET16tXL016/fn0FBwd7IyZ4ir0oAACAF7Rq1UqdOnXSnj179PLLL+vAgQN69NFHnQk0Sbrpppt0+PDhIp/z2WefVb169RQaGqqOHTtq8+bNBfY/duyYRo4cqdq1ayskJEQXX3yxPv3002K/JwAAAG/xOIk2atQoPfLIIzp9+rSz7fTp05o5c6ZGjRrl1eAAAABQegYOHKi9e/fqk08+Ub9+/RQYGJinT82aNZWdnV2k8y1fvlzjx4/XtGnTtG3bNrVp00Y9e/bUoUOH3PbPyMhQjx49tHfvXr3zzjvauXOnFi1apDp16pzX+wIAAPCGIi3nvO6661yer1mzRhdeeKHatGkjSfr++++VkZGh//znP96PEAAAAKUid++zc508eVJPPPGEpk6d6tH55s2bpxEjRigxMVGStHDhQn3yySd65ZVXNHny5Dz9X3nlFf3zzz/asGGDgoKCJMntCgj4B1OmJFZEAAAqjiLNRIuMjHR5XH/99brmmmsUGxur2NhYXXPNNbruuusUGRlZ0vECAACghMyYMUPp6el52h0Oh2bMmOHRuTIyMrR161Z1797d2RYQEKDu3btr48aNbo/58MMPFR8fr5EjRyo6OlotW7bUrFmzlJWV5bb/6dOnlZaW5vJA6UlYnCCzmJXhAQAoi4o0E23x4sUlHQcAAAB8zDRNGW72Wv3+++9VvXp1j8515MgRZWVlKTo62qU9OjpaO3bscHvM7t27tW7dOt1888369NNPtWvXLt19993KzMzUtGnT8vSfPXu2x8k9nB9LkEVxMXFKTklWckqyHJkOhee+SEINAFDOebwnGgAAAMqXatWqqXr16jIMQxdffLGqV6/ufERGRqpHjx4aOHBgiceRnZ2tqKgovfjii2rXrp0GDRqkBx54QAsXLnTbf8qUKTp+/LjzceDAgRKPsaIzDENJiUnuX0xIIJEGACjXijQT7VzvvPOO3nrrLe3fv18ZGRkur23bts0rgQEAAKB0zJ8/X6Zp6rbbbtOMGTNctugIDg5WvXr1FB8f79E5a9asqcDAQKWmprq0p6amKiYmxu0xtWvXVlBQkEtBg2bNmiklJUUZGRl5KsGHhIQoJCTEo7hw/oyz90GzWKS4OCk5OefhcEjh4fkcCQBA2eZxEu3pp5/WAw88oGHDhumDDz5QYmKifv/9d23ZskUjR44siRjhA/ZMe542S5DF7RIPAABQtg0dOlSSVL9+fXXu3Nm5qf/5CA4OVrt27bR27Vr169dPUs5Ms7Vr1+Zb0d1qter1119Xdna2AgJyFkz8+uuvql27dp4EGvyEYUhJSVLlyr6OBACAEudxEu25557Tiy++qJtuuklLlizRxIkT1aBBA02dOlX//PNPScQIH4ieE52nzRprVVJiEok0AADKkbS0NFWpUkWS1LZtW508eVInT5502ze3X1GNHz9eQ4cOVfv27dWhQwfNnz9fdrvdWa1zyJAhqlOnjmbPni1Juuuuu/TMM89o7NixGj16tH777TfNmjVLY8aMOY93iBLH2BAAUEF4nETbv3+/OnfuLEkKCwvTiRMnJEm33nqrOnXqpGeeeca7EaLUWIIsssZaZTtgc/u67YAtZ/PYYKboAwBQXlSrVk0HDx5UVFSUqlat6vZmWW7BgfyqZOZn0KBBOnz4sKZOnaqUlBTFxcVp5cqVzmID+/fvd844k6TY2FitWrVK48aNU+vWrVWnTh2NHTtWkyZNOr83CQAA4AUeJ9FiYmL0zz//qG7durrooou0adMmtWnTRnv27KHEdRmXu1GsI9Ph0m7PtLudmQYAAMq+devWOStvfvHFF14//6hRo/Jdvrl+/fo8bfHx8dq0aZPX4wAAADhfHifRrrjiCn344Ydq27atEhMTNW7cOL3zzjv69ttvdd1115VEjChFhmEw0wwAgAqka9eubr8GAACAK4+TaC+++KKys7MlSSNHjlSNGjW0YcMG9e3bV//3f//n9QABAABQcn744Yci923dunUJRgIAAODfPE6iBQQEuOxdceONN+rGG2/0alAAAAAoHXFxcTIMo9BtOYqzJxoAAEB54nESTZKOHj2ql19+Wdu3b5ckNW/eXImJic79NAAAAFA27Nmzx9chAAAAlAkBhXdx9dVXX6l+/fp6+umndfToUR09elRPP/206tevr6+++srjAJ599lnVq1dPoaGh6tixozZv3lxg/2PHjmnkyJGqXbu2QkJCdPHFF+vTTz/1+LoAAACQ6tatW+QHcC57pp3iYgCACsPjmWgjR47UwIED9fzzzyswMFCSlJWVpbvvvlsjR47Ujz/+WORzLV++XOPHj9fChQvVsWNHzZ8/Xz179tTOnTsVFRWVp39GRoZ69OihqKgovfPOO6pTp4727dunqlWrevo2AAAAIOnDDz9Ur169FBQUpA8//LDAvn379i2lqFBWRM+J1n+iOmlNboPdXrIXtFgkwyjZawAAkA/D9PDWUVhYmJKTk9WkSROX9p07dyouLk4nT54s8rk6duyoSy+9VM8884wkKTs7W7GxsRo9erQmT56cp//ChQv1xBNPaMeOHQoKCvIkbKe0tDRFRkbq+PHjqlKlSrHO4XfsdikiIufr9HQp3LvVNe0ZdkXMzjl/+pR0qncCACqkcjmGUM5+tykpKYqKinLZ9/ZcZWFPtPL6M/I3pmkqYXGCbAdskiRLhmSfVUoXt1qlpCQSaQAAryrqGMLj5ZyXXHKJcy+0s23fvl1t2rQp8nkyMjK0detWde/e/d9gAgLUvXt3bdy40e0xH374oeLj4zVy5EhFR0erZcuWmjVrVoEDutOnTystLc3lAQAAgBzZ2dnOFQDZ2dn5Pvw9gYbSYxiGkhKTlDohVZLkCJKyOseXzsVtNsnhKJ1rAQBwjiIt5zy79PmYMWM0duxY7dq1S506dZIkbdq0Sc8++6weffTRIl/4yJEjysrKUnR0tEt7dHS0duzY4faY3bt3a926dbr55pv16aefateuXbr77ruVmZmpadOmuT1m9uzZmjFjRpHjAgAAAFAwwzAUHvT/VycY0ql1qxV+pgRnh9nt0jn/bgAAoLQVKYnmrvT5xIkT8/QbPHiwBg0a5L3ozpF7p/TFF19UYGCg2rVrpz///FNPPPFEvkm0KVOmaPz48c7naWlpio2NLbEYAQAAyrK1a9fqySefdK48aNasme655x6X1QNAHobh9S1FAADwN0VKopVE6fOaNWsqMDBQqampLu2pqamKiYlxe0zt2rUVFBTkLGgg5QzsUlJSlJGRoeDg4DzHhISEKCQkxLvB+7PczVzZdBUAAHjoueee09ixYzVgwACNHTtWUs6Kg969e+vJJ5/UyJEjfRwhAACA7xQpiVYSJc2Dg4PVrl07rV27Vv369ZOUM9Ns7dq1GjVqlNtjrFarXn/9dWVnZzs3vv31119Vu3Zttwm0Cil3mjubrgIAAA/NmjVLTz75pMtYbMyYMbJarZo1axZJNAAAUKF5XFhAkn7//XeNHj1a3bt3V/fu3TVmzBj9/vvvHp9n/PjxWrRokV599VVt375dd911l+x2uxITEyVJQ4YM0ZQpU5z977rrLv3zzz8aO3asfv31V33yyScM6KScWWdWq2sbm64CAAAPHTt2TFdddVWe9iuvvFLHjx/3QUQAAAD+w+Mk2qpVq9S8eXNt3rxZrVu3VuvWrfXNN9+oRYsW+vzzzz0616BBgzRnzhxNnTpVcXFxSk5O1sqVK53FBvbv36+DBw86+8fGxmrVqlXasmWLWrdu7SxyMHnyZE/fRvliGDmzztLTpXOWxwIAABRV37599f777+dp/+CDD3TNNdf4ICIAAAD/UaTlnGebPHmyxo0bl6cS5+TJkzVp0iT16NHDo/ONGjUq3+Wb69evz9MWHx+vTZs2eXSNCoHNXAEAQDE8/fTTzq+bN2+umTNnav369YqPj5eUsyeazWbTvffe66sQAQAA/IJhnl1yswhCQ0P1448/qnHjxi7tv/76q1q3bq1Tp055NUBvS0tLU2RkpI4fP64qVar4Ohzvs9uliIicr9PTvZJYs2fYFTE755zpU9IVHkyyDgBQ8ZTXMUT9+vWL1M8wDO3evbuEozk/5fVn5K9KdYxYAmNcAAByFXUM4fFMtFq1aik5OTlPEi05OVlRUVGeRwoAAACfKYkq7AAAAOWRx0m0ESNG6I477tDu3bvVuXNnSZLNZtNjjz2m8ePHez1AAAAAAP7Nnmk/73NYgiwyilJZ3rOFNAAAeI3HSbSHHnpIlStX1ty5c52VMy+44AJNnz5dY8aM8XqAAAAAKD1//PGHPvzwQ+3fv18ZGRkur82bN89HUcHfRc+JPu9zWGOtSkpMKjyRlpAgbduWsycwAAClyKMk2pkzZ/T6669r8ODBGjdunE6cOCFJqly5cokEBwAAgNKzdu1a9e3bVw0aNNCOHTvUsmVL7d27V6Zp6pJLLvF1ePAzliCLrLFW2Q7YvHI+2wGbHJkO93urWSxSXJyUnJzzcDjYFw0AUOo8SqJVqlRJd955p7Zv3y6J5BkAAEB5MmXKFE2YMEEzZsxQ5cqV9e677yoqKko333yzrrrqKl+HBz9jGIaSEpPkyHSc13nsmfbCZ7IZhpSUJPHvDwCAD3m8nLNDhw767rvvVLdu3ZKIBwAAAD6yfft2vfHGG5Jybp6ePHlSERERevjhh3Xttdfqrrvu8nGE8DeGYZRe5XaWbwIAfMzjJNrdd9+te++9V3/88YfatWun8HOmUbdu3dprwQEAAKD0hIeHO/dBq127tn7//Xe1aNFCknTkyBFfhgYAAOBzHifRbrzxRklyKSJgGIZM05RhGMrKyvJedDg/djdVkiwW7uIBAAC3OnXqpK+//lrNmjVT7969de+99+rHH3/Ue++9p06dOvk6PAAAAJ/yOIm2Z8+ekogDJSHazd4SVmvOfhIk0gAAwDnmzZun9PR0SdKMGTOUnp6u5cuXq3HjxlTmBAAAFZ7HSTT2QvNzFktOosyWT5Ukm+28qhnZM11nt1mCLIWXIQcAAGVCgwYNnF+Hh4dr4cKFPowGAADAv3icRJOknTt3asGCBc4qnc2aNdPo0aPVpEkTrwaHYsitXOQ4p0qS3e5+ZpqHzq2cZI21KikxiUQaAADlyLfffusc5zVv3lzt2rXzcUQAAAC+F+DpAe+++65atmyprVu3qk2bNmrTpo22bdumli1b6t133y2JGOEpw8iZaXbuo5gsQRZZY61uX7MdsJ13WXMAAOAf/vjjDyUkJKhDhw4aO3asxo4dq0svvVSXXXaZ/vjjD1+HBwAA4FMez0SbOHGipkyZoocfftilfdq0aZo4caKuv/56rwUH/2AYhpISk1ySZfZMe55ZaQAAoGy7/fbblZmZqe3btztXGOzcuVOJiYm6/fbbtXLlSh9HCAAA4DseJ9EOHjyoIUOG5Gm/5ZZb9MQTT3glKPgfwzAUHlz82WwAAMD/ffnll9qwYYPLFh1NmjTRggULlJCQ4MPIgHO4q0Kfi2r0AIAS4nESrVu3bkpKSlKjRo1c2r/++msGVwAAAGVYbGysMjMz87RnZWXpggsu8EFEqGjOLWLlIsMu5y3dgvb6pRo9AKCEeJxE69u3ryZNmqStW7eqU6dOkqRNmzbp7bff1owZM/Thhx+69AUAAEDZ8MQTT2j06NF69tln1b59e0k5RQbGjh2rOXPm+Dg6VAQFbhdiSkmx0mUHCjnJeVajBwAgP4ZpmqYnBwQEFK0WgWEYysrKKlZQJSktLU2RkZE6fvy4qlSp4utwSo/dLkVE5Hydnn7egwp7hl0Rs3POlz4lnaWeAIByr7yOIapVq+ZSZdtut+vMmTOqVCnnXmvu1+Hh4frnn398FWaRlNefUXlnmqYSFifIdsBWhM6S5azJkocmpP47Dj27Gr0XxrsAgIqjqGMIj2eiZWdnn1dgAAAA8B/z58/3dQio4NwVsSqIS4Gr8HCJm7kAgFLicRINAAAA5cfQoUN9HQJAESsAQJlAEg0AAABOWVlZWrFihbZv3y5JatGihfr27avAwEAfRwYAAOBbJNEqIs+2wQMAABXErl271Lt3b/35559q0qSJJGn27NmKjY3VJ598ooYNG/o4QgAAAN8pWpUAlC8JCSTSAABAHmPGjFHDhg114MABbdu2Tdu2bdP+/ftVv359jRkzxtfhAQAA+BQz0SoKi0WKi5OSk3MelP0GAADn+PLLL7Vp0yZVr17d2VajRg09+uijslqtPowMAADA94qVRMvOztauXbt06NChPNU6u3Tp4pXA4GWGISUlSZUr+zoSAADgp0JCQnTixIk87enp6QoODvZBRAAAAP7D4yTapk2bNHjwYO3bt0/mOUsCDcNQVlaW14KDlxlGiZzWFEtDAQAoD6655hrdcccdevnll9WhQwdJ0jfffKM777xTffv29XF0AAAAvuXxnmh33nmn2rdvr59++kn//POPjh496nz8888/JREj/FzC4oQ8CVUAAFD2PP3002rYsKHi4+MVGhqq0NBQWa1WNWrUSE899ZSvwwOKzm5nD2AAgNd5PBPtt99+0zvvvKNGjRqVRDwoIyxBFsXFxCk5JVnJKclyZDoUHsweawAAlFWmaSotLU1vvvmm/vzzT23fvl2S1KxZM8Z9KHuioyWrNWc7kxJajQEAqHg8TqJ17NhRu3btYjBVwRmGoaTEJFWezR5rAACUB6ZpqlGjRvr555/VuHFjxnooE+yZ9n+fVDIV2jlegRs25jy32WQ/dvi8i2lZgiwySMQBAFSMJNro0aN17733KiUlRa1atVJQUJDL661bt/ZacPBvhhhMAABQXgQEBKhx48b6+++/1bhxY1+HAxRJ9Jxo14YeUq3O0qE5OU+j5kTLcZ41MayxViUlJpFIAwB4nkS7/vrrJUm33Xabs80wDJmmSWEBAACAMuzRRx/Vfffdp+eff14tW7b0dTiAW5Ygi6yxVtkO2PK+aEh2LxeStR2wsXUJAEBSMZJoe/bsKYk4AAAA4GNDhgyRw+FQmzZtFBwcrLCwMJfXKSIFf5C7rYgj0+G+g90uzcqZoXZoQmqxl3PaM+15Z7oBACo0j5NodevWLYk4AAAA4GPz58/3dQhAkRiGkf/MsMx/vwwPDpeYQQYA8BKPk2iS9Pvvv2v+/PnOqk3NmzfX2LFj1bBhQ68GBwAAgNIzdOhQX4cAAADgtzxOoq1atUp9+/ZVXFycrFarJMlms6lFixb66KOP1KNHD68HiRJgt0sWCyW/AQCAi6ysLL3//vsuN0uvvfZaVapUrHuvAAAA5YbHo6HJkydr3LhxevTRR/O0T5o0iSRaWREdLVmtUlISiTQAACBJ+vnnn9W3b1+lpKSoSZMmkqTHHntMtWrV0kcffUSxAQAAUKEFeHrA9u3bNXz48Dztt912m3755RevBIUSYrHkJM5y2WySI58NWQEAQIVz++23q0WLFvrjjz+0bds2bdu2TQcOHFDr1q11xx13+Do8AAAAn/J4JlqtWrWUnJysxo0bu7QnJycrKirKa4GhBBhGzsyzw4dzZqIBAACcJTk5Wd9++62qVavmbKtWrZpmzpypSy+91IeRAQAA+J7HSbQRI0bojjvu0O7du9W5c2dJOXuiPfbYYxo/frzXA4SXGUaxy3wDAIDy7eKLL1ZqaqpatGjh0n7o0CE1atTIR1EB58Fuz9vGvsAAgGLyOIn20EMPqXLlypo7d66mTJkiSbrgggs0ffp0jRkzxusBAgAAoHTMnj1bY8aM0fTp09WpUydJ0qZNm/Twww/rscceU1pamrNvlSpVfBUmUHTuVl+wLzAAoJgM0zTN4h584sQJSVLlypW9FlBJS0tLU2RkpI4fP15xB392uxQRkfN1enqxZ6bZM+yKmJ1zntQJqQoPKt55LEEWGQxiAAB+riKMIQIC/t0uN/ezOXeoePZzwzCUlZVV+gEWoiL8jFAEpiklJOTs/5ufIoyBzx7rpk9JV3gwqzkAoLwq6hjivGqVl6XkGUpW9Jzi77FmjbUqKTGJRBoAAD72xRdf+DoE4Pzl7gN8bgEtu519gQEA56VISbRLLrlEa9euVbVq1dS2bdsCkx3btm3zWnDwb5Ygi6yxVtkOFHCXrwhsB2xyZDq4uwcAgI917drV1yEA3uHlfYDtmW72VisGVmAAQNlWpCTatddeq5CQEElSv379SjIelCGGYSgpMUmOTEfhnd2wZ9rPawYbAAAAUBq8NWZlBQYAlG1FSqJNmzbN7deAYRjMIAMAAEC5461VF2djBQYAlG0e74l24MABGYahCy+8UJK0efNmvf7662revLnuuOMOrwcIAAAAAKXtfFddnI0VGABQPnicRBs8eLDuuOMO3XrrrUpJSVH37t3VsmVLLVu2TCkpKZo6dWpJxAkAAAAApYpVFwCAswUU3sXVTz/9pA4dOkiS3nrrLbVq1UobNmzQsmXLtGTJEm/Hh5Jmt+c8/n/5egAAAAAAAOTl8Uy0zMxMZ5GBNWvWqG/fvpKkpk2b6uDBg96NDiUvt8y31ZpTCpxNTgEAqFAKq7x+NqqwAwCAiszjJFqLFi20cOFCXX311fr888/1yCOPSJL++usv1ahRw+sBogRYLDlJM9tZm6TabJLD4dVS4AAAwP9ReR0AAKBoPE6iPfbYY+rfv7+eeOIJDR06VG3atJEkffjhh85lnvBzhpEz68zhyFnKGc0mpwAAVFRUXkeFxFYmAIBi8DiJ1q1bNx05ckRpaWmqVq2as/2OO+6QxWLxanAoQYbBrDMAAABUTAkJ0rZtbGUCAPCIx4UFTp48qdOnTzsTaPv27dP8+fO1c+dORUVFeT1AAAAAlI6srCzNmTNHHTp0UExMjKpXr+7yAMo0i0WKi8v5Ojk5Z1UGAAAe8DiJdu2112rp0qWSpGPHjqljx46aO3eu+vXrp+eff97rAQIAAKB0zJgxQ/PmzdOgQYN0/PhxjR8/Xtddd50CAgI0ffp0X4cHnJ/cLU0AACgmj5No27ZtU0JCgiTpnXfeUXR0tPbt26elS5fq6aef9nqAAAAAKB3Lli3TokWLdO+996pSpUq66aab9NJLL2nq1KnatGmTr8MDzh/LNwEA58HjPdEcDocqV64sSVq9erXz7mSnTp20b98+rweIisGeaXd5bgmyyGCQAwBAqUpJSVGrVq0kSRERETp+/Lgk6ZprrtFDDz3ky9CAcuPccW9xMV4GgNLncRKtUaNGWrFihfr3769Vq1Zp3LhxkqRDhw6pSpUqXg8QFUP0HNcKodZYq5ISkxgYAABQii688EIdPHhQF110kRo2bKjVq1frkksu0ZYtWxQSEuLr8IBy4dxxb3ExXgaA0ufxcs6pU6dqwoQJqlevnjp06KD4+HhJObPS2rZt6/UAUX5ZgiyyxlrdvmY7YJMjk81eAQAoTf3799fatWslSaNHj9ZDDz2kxo0ba8iQIbrtttt8HB1QdhU07i0uxssAUPoM0zRNTw9KSUnRwYMH1aZNGwUE5OThNm/erCpVqqhp06ZeD9Kb0tLSFBkZqePHjzNzTpLsdikiIufr9HQpPLxUL2+apsuHvz3T7rw7lz4lXeHBpRsPAAD5qYhjiE2bNmnDhg1q3Lix+vTp4+twClURf0bwkA/HvueOe4uL8TIAeF9RxxAeL+eUpJiYGKWnp+vzzz9Xly5dFBYWpksvvZSpxPCYYRh88AMA4CdOnTql0NBQ5/NOnTqpU6dOPowIKD8Y9wJA2efxcs6///5b//nPf3TxxRerd+/eOnjwoCRp+PDhuvfee70eIAAAAEpHVFSUhg4dqs8//1zZ2dm+DgcAAMCveJxEGzdunIKCgrR//35ZLBZn+6BBg7Ry5UqvBgcAAIDS8+qrr8rhcOjaa69VnTp1dM899+jbb7/1dVgAAAB+wePlnKtXr9aqVat04YUXurQ3btxY+/bt81pgAAAAKF39+/dX//79deLECb3zzjt644031KlTJzVo0EC33HKLpk6d6usQAe+x2713LotFYmsbACj3PJ6JZrfbXWag5frnn38ofQ4AAFAOVK5cWYmJiVq9erV++OEHhYeHa8aMGb4OC/Cu6OicIgPeeCQkSJ7XawMAlDEeJ9ESEhK0dOlS53PDMJSdna3HH39cl19+uVeDAwAAQOk7deqU3nrrLfXr10+XXHKJ/vnnH913332+Dgs4fxaLZLV6/7w2m+Q4/8qbAAD/5vFyzscff1z/+c9/9O233yojI0MTJ07Uzz//rH/++Uc2m60kYgQAAEApWLVqlV5//XWtWLFClSpV0oABA7R69Wp16dLF16EB3mEYUlKS9xJednvOjDYAQIXgcRKtZcuW+vXXX/XMM8+ocuXKSk9P13XXXaeRI0eqdu3aJREjAAAASkH//v11zTXXaOnSperdu7eCgoJ8HRLgfYYhhYf7OgoAQBnkURItMzNTV111lRYuXKgHHnigpGICAACAD6Smpqpy5cq+DgMAAMAveZRECwoK0g8//FBSsQAAAKCUpaWlqUqVKpIk0zSVlpaWb9/cfgAAABWRx4UFbrnlFr388sslEQsAAABKWbVq1XTo0CFJUtWqVVWtWrU8j9x2AACAiszjPdHOnDmjV155RWvWrFG7du0Ufs5+AvPmzfNacKjY7Jl2WYIsMgzD16EAAFBurVu3TtWrV3d+zecuAACAex4n0X766SddcsklkqRff/3V5TUGXfCm6DnRssZalZSYxO8WAAAlpGvXrs6vu3Xr5rtAAAAA/JzHSbQvvviiJOIAJEmWIIussVbZDtgkSbYDNjkyHQoPpoISAAAlrXHjxrr55pt18803q3Hjxr4OBwAAwK94vCcaUJIMw1BSYpJSJ6T6OhQAACqcu+++W5988omaNm2qSy+9VE899ZRSUlJ8HRYAAIBf8HgmWv/+/d0urTMMQ6GhoWrUqJEGDx6sJk2aeCVAVDyGYSg8iJlnAACUtnHjxmncuHH69ddftWzZMj377LOaMGGCLr/8ct1yyy0aMmSIr0MEAADwGY9nokVGRmrdunXatm2bDMOQYRj67rvvtG7dOp05c0bLly9XmzZtZLPZSiJeAAAAlLCLL75YM2bM0K+//qqkpCQdPnxYiYmJxTrXs88+q3r16ik0NFQdO3bU5s2bi3Tcm2++KcMw1K9fv2JdFwAAwNs8TqLFxMRo8ODB2r17t9599129++67+v3333XLLbeoYcOG2r59u4YOHapJkyaVRLwAAAAoBZs3b9Y999yj/v3769dff9UNN9zg8TmWL1+u8ePHa9q0adq2bZvatGmjnj176tChQwUet3fvXk2YMEEJCQnFDR8AAMDrPE6ivfzyy7rnnnsUEPDvoQEBARo9erRefPFFGYahUaNG6aeffvJqoAAAAChZv/76q6ZNm6aLL75YVqtV27dv12OPPabU1FS9+eabHp9v3rx5GjFihBITE9W8eXMtXLhQFotFr7zySr7HZGVl6eabb9aMGTPUoEGDAs9/+vRppaWluTwAAABKisdJtDNnzmjHjh152nfs2KGsrCxJUmhoqNt90wAAAOC/mjZtqpUrV2rkyJH6448/tGrVKg0ZMkQREREenysjI0Nbt25V9+7dnW0BAQHq3r27Nm7cmO9xDz/8sKKiojR8+PBCrzF79mxFRkY6H7GxsR7HCQAAUFQeFxa49dZbNXz4cN1///269NJLJUlbtmzRrFmznJvNfvnll2rRooV3IwUAAECJycrK0gsvvKABAwaoWrVq532+I0eOKCsrS9HR0S7t0dHRbm/IStLXX3+tl19+WcnJyUW6xpQpUzR+/Hjn87S0NBJpAACgxHicRHvyyScVHR2txx9/XKmpqZJyBkPjxo1z7oN25ZVX6qqrrvJupAAAACgxgYGBGj16tLp37+6VJJqnTpw4oVtvvVWLFi1SzZo1i3RMSEiIQkJCSjgyAACAHB4n0QIDA/XAAw/ogQcecO47UaVKFZc+F110kXeiAwAAQKlp2bKldu/erfr165/3uWrWrKnAwEDnTddcqampiomJydP/999/1969e9WnTx9nW3Z2tiSpUqVK2rlzpxo2bHjecQEAABSXx3ui5Tp8+LB++OEH/fDDDzpy5Ig3YwIAAIAP/Pe//9WECRP08ccf6+DBg+e1aX9wcLDatWuntWvXOtuys7O1du1axcfH5+nftGlT/fjjj0pOTnY++vbtq8svv1zJycks0wQAAD7n8Uw0u92u0aNHa+nSpc67g4GBgRoyZIgWLFggi8Xi9SABAABQ8nr37i1J6tu3r0uRKNM0ZRiGs4hUUY0fP15Dhw5V+/bt1aFDB82fP192u12JiYmSpCFDhqhOnTqaPXu2QkND1bJlS5fjq1atKkl52gEAAHzB4yTa+PHj9eWXX+qjjz6S1WqVlLMJ7JgxY3Tvvffq+eef93qQAAAAKHlffPGFV883aNAgHT58WFOnTlVKSori4uK0cuVKZ7GB/fv3KyCg2AsjAAAASpVhmqbpyQE1a9bUO++8o27durm0f/HFFxo4cKAOHz7szfi8Li0tTZGRkTp+/HievdwqJLtdyi1bn54uhYf7Np7/z55hV8TsnLjSp6QrPNg/4gIAVFyMIfwfPyOUOh+MpRknA4D3FXUM4fFMNIfDkadUuSRFRUXJ4XB4ejqgUPZM+3kdbwmyuCxJAQAA7n311VcFvt6lS5dSigQAAMD/eJxEi4+P17Rp07R06VKFhoZKkk6ePKkZM2a43SQWZYj9/yerLBbJj5JO0XPyJm09YY21KikxiUQaAACFOHelgSSXz09P90QDAAAoTzxOos2fP19XXXWVLrzwQrVp00aS9P333ys0NFSrVq3yeoAoRbkzDK1WKSnJp4k0S5BF1lirbAds530u2wGbHJkOproDAFCIo0ePujzPzMzUd999p4ceekgzZ870UVQAAAD+weMkWqtWrfTbb79p2bJl2rFjhyTppptu0s0336ywsDCvB4gSZrHkJM1sZyWrbDbJ4fDp/miGYSgpMUmOzOIvEbZn2s97FhsAABVJZGRknrYePXooODhY48eP19atW30QFQAAgH/wKImWmZmppk2b6uOPP9aIESNKKiaUJsPImXXmcOQs53Sz352vGIbB7DEAAPxAdHS0du7c6eswAAAAfMqjmuJBQUE6deqU14N49tlnVa9ePYWGhqpjx47avHlzkY578803ZRiG+vXr5/WYKhTDyJl15ieVOQEAgG/88MMPLo/vv/9eK1eu1J133qm4uDhfhwcAAOBTHi/nHDlypB577DG99NJLqlTJ48PzWL58ucaPH6+FCxeqY8eOmj9/vnr27KmdO3cqKioq3+P27t2rCRMmKCEh4bxjAAAAgBQXFyfDMGSapkt7p06d9Morr/goKgAAAP/gcRZsy5YtWrt2rVavXq1WrVop/JzZS++9955H55s3b55GjBihxMRESdLChQv1ySef6JVXXtHkyZPdHpOVlaWbb75ZM2bMUFJSko4dO+bp2wAAAMA59uzZ4/I8ICBAtWrVclZkBwAAqMg8TqJVrVpV119/vVcunpGRoa1bt2rKlCnOtoCAAHXv3l0bN27M97iHH35YUVFRGj58uJKSkgq8xunTp3X69Gnn87S0tPMPHAAAoByqW7eur0MAAADwWx4n0RYvXuy1ix85ckRZWVmKPmcz++joaGflz3N9/fXXevnll5WcnFyka8yePVszZsw431ABAADKrY0bN+rvv//WNddc42xbunSppk2bJrvdrn79+mnBggUKCQnxYZQAAAC+5VFhgbMdOnRISUlJSkpK0qFDh7wZU75OnDihW2+9VYsWLVLNmjWLdMyUKVN0/Phx5+PAgQMlHCUAAEDZ8vDDD+vnn392Pv/xxx81fPhwde/eXZMnT9ZHH32k2bNn+zBCAAAA3/N4JlpaWppGjhypN998U1lZWZKkwMBADRo0SM8++6wiIyOLfK6aNWsqMDBQqampLu2pqamKiYnJ0//333/X3r171adPH2dbdnZ2zhupVEk7d+5Uw4YNXY4JCQnhrikAAEABkpOT9cgjjzifv/nmm+rYsaMWLVokSYqNjdW0adM0ffp0H0UIwB1TZuGdAABe4/FMtBEjRuibb77Rxx9/rGPHjunYsWP6+OOP9e233+r//u//PDpXcHCw2rVrp7Vr1zrbsrOztXbtWsXHx+fp37RpU/34449KTk52Pvr27avLL79cycnJio2N9fTtAAAAVHhHjx512V7jyy+/VK9evZzPL730UmbzA4Wx2yWzdJNaCYsT8lTTBQCUHI9non388cdatWqVLrvsMmdbz549tWjRIl111VUeBzB+/HgNHTpU7du3V4cOHTR//nzZ7XZntc4hQ4aoTp06mj17tkJDQ9WyZUuX46tWrSpJedoBAABQNNHR0dqzZ49iY2OVkZGhbdu2uewpe+LECQUFBfkwQqAMiI6WrFYpKUkyjBK7jCXIoriYOCWnJCs5JVmOTIfCg8NL7HoAgH95nESrUaOG2yWbkZGRqlatmscBDBo0SIcPH9bUqVOVkpKiuLg4rVy50nk3dP/+/QoIKPbWbSguu919u8VSooMCAABQ+nr37q3Jkyfrscce04oVK2SxWJSQkOB8/YcffsizZQYA5YyNrVbJZst5brNJDocUXnJJLcMwlJSYpMqzK5fYNQAA7nmcRHvwwQc1fvx4vfbaa859y1JSUnTffffpoYceKlYQo0aN0qhRo9y+tn79+gKPXbJkSbGuiUKcUzHVqRTurpUEe6ZdliCLjDIWNwAApeGRRx7Rddddp65duyoiIkKvvvqqgoODna+/8soruvLKK30YIeCnDCNnbHz4cP7j55K4rBjTAoAveJxEe/7557Vr1y5ddNFFuuiiiyTlzBYLCQnR4cOH9cILLzj7btu2zXuRouSdeyfNnVK4u1YSoudEyxprVVJiEok0AADOUbNmTX311Vc6fvy4IiIiFBgY6PL622+/rYiICB9FB/g5wyhzY2MAQPF4nETr169fCYQBv5B7J83hyPua3V6qd9e8wRJkkTXWKtuBnKSg7YCNPSMAAChAflXWq1evXsqRAAAA+B+Pk2jTpk0riTjgL8rRnbTc/SIOOw4rek7ZSgACAAAAAAD/wo79KNcMw1B4UPlICgIAAAAAAN8hiQYAAAAAAAAUgiQaAAAAAAAAUAiSaAAAAAAAAEAhziuJZpqmTNP0ViwAAAAAAACAXypWEm3p0qVq1aqVwsLCFBYWptatW+u1117zdmwAAAAAULbY7XkfTDwAgHKhkqcHzJs3Tw899JBGjRolq9UqSfr6669155136siRIxo3bpzXgwQAAACAMiE6Om+b1SolJUmG4fXL2TPtBb5uCbLIKIHrAkBF5HESbcGCBXr++ec1ZMgQZ1vfvn3VokULTZ8+nSQaAAAAgIrFYslJlNls7l+32SSHQwoP9/qlo+e4SdqdxRprVVJiEok0APACj5dzHjx4UJ07d87T3rlzZx08eNArQcHPMTUdAAAA+Jdh5Mw0S093faSmlsjlLEEWWWOtReprO2CTI9NRInEAQEXj8Uy0Ro0a6a233tL999/v0r58+XI1btzYa4HBj509Rb0Ep6YDAAAAZYZhlMhMM/eXMpSUmFRgcsyeaS90lhoAwDMeJ9FmzJihQYMG6auvvnLuiWaz2bR27Vq99dZbXg8QfiK/KeolODUdAAAAgHuGYSg8mDE4AJQmj5No119/vb755hs9+eSTWrFihSSpWbNm2rx5s9q2bevt+OAvcqeoO/7/3S673f2mqX7u3I1X2WgVAAAAAAAUhcdJNElq166d/ve//3k7Fvi7UpyiXlLOndLORqsAAAAAAKAoPC4sAJQ1BW28ykarAAAAAACgKIo8Ey0gIKDQ2TqGYejMmTPnHRTgTe42XmWjVQAAAAAA4IkiJ9Hef//9fF/buHGjnn76aWVnZ3slKMDb2HgVAAAAAACcjyIn0a699to8bTt37tTkyZP10Ucf6eabb9bDDz/s1eAAAAAAAAAAf1CsPdH++usvjRgxQq1atdKZM2eUnJysV199VXXr1vV2fAAAAABQ9tntrg/T9HVEAAAPeZREO378uCZNmqRGjRrp559/1tq1a/XRRx+pZcuWJRUfAAAAAJR90dFSRMS/j4QEEmkAUMYUOYn2+OOPq0GDBvr444/1xhtvaMOGDUpISCjJ2AAAAACg7LJYJKv7KvGy2SQHVeIBoCwp8p5okydPVlhYmBo1aqRXX31Vr776qtt+7733nteCAwAAAIAyyzCkpCTXZJndnjMrrRTZM+0lcl5LkEWGYZTIuQHAHxU5iTZkyBD+Bwn37P//Q9liyRkoAAAAAMhhGFK4b6vER88pmaSdNdaqpMQk/p0IoMIochJtyZIlJRgGyrTcO2lWa86dNj5EAQAAAJ+yBFlkjbXKdsBWYtewHbDJkelQeLBvk4QAUFqKnEQDXOTu72A760M5d18HH99pAwAAACo6wzCUlJgkR6b3912zZ9pLbHYbAPgzkmgonrP3d/DBvg4AAAAACmYYBrPEAMCLSKKh+PxgfwcAAAAAAIDSQBINFZ67akVUGgIAAAAAAGcjiYYKz91+DlQaAgAAAAAAZwvwdQCAL+RWK8pPbqUhAAAAAAAAiZloqKDyq1ZEpSEAAACUGtP0dQQAAA+QREOFRbUiAAAA+FRCgrRtW07BLgCA32M5JwAAAACUFotFiovL+To5WXKwhQgAlBUk0QAAAACgtBiGlJTk6ygAAMVAEg0AAAAAShPLNwGgTGJPNHiX3Z4zRZ2BAQAAAFDu2TPtvg7ByRJkkcG/QwCUIJJo8K7oaMlqzZmizgcYAAAAUK75U2V7a6xVSYlJJNIAlBiWc+L8WSw5ibNcNhsbpAIAAADllCXIImustfCOpcx2wCZHJv8OAVBymImG85e7Oerhwzkz0QAAAACUW4ZhKCkxyW8SVvZMu1/NiANQfpFEg3cYhhQe7usoAAAAAJQCwzAUHsz4H0DFwnJOAAAAAAAAoBAk0QAAAAAAAIBCkEQDAAAAAF8xTV9HAAAoIvZEA/Jhz7QX2scSZKGENgAAAIovIUHati1nj2EAgF8jiQbkoygVfqyxViUlJpFIAwAAQNFZLFJcnJScnPNwOCjSBQBlAMs5gbNYgiyyxlqL3N92wOY3pb0BAABQRhiGlJTk6ygAAB5iJhpwFsMwlJSYVGhizJ5pL9JMNQAAAMAtVjIAQJlDEg04h2EYCg9mOj0AAAAAAPgXSTSUDHs+m/JbLNx1AwAAAAAAZQ5JNJSM6HyWOlqtOfs/kEgDAAAAAABlCIUF4D0WS06SrCA2W071IQAAAAAAgDKEmWjwntwqQ+6SZHZ7/rPTAAAAAAAA/BxJNHiXYUjhbMoPAAAAAADKF5ZzAgAAAAAAAIVgJhoAAAAA+JJp+jqCcsOeafd1CCXCEmSRQXE2wOdIogEAAACALyUkSNu2UcHeC6LnlM99mK2xViUlJpFIA3yM5ZwAAAAAUNosFikuLufr5GQq2J8HS5BF1lirr8MoUbYDNjky+R0BfI2ZaAAAAABQ2nIr21eu7OtIyjzDMJSUmFQuk0z2THu5nV0HlEUk0QAAAADAF1ia5zWGYSg8ONzXYQAo51jOCQAAAAAAABSCmWjAeXJXAYjqOQAAAAAAlC8k0YDz5G6PAqrnAAAAAABQvrCcE6XPNH0dwXkrrAIQ1XMAAAAAAChfmImG0peQIG3bVqY3Us2vAhDVcwAAAAAAKJ+YiYbSYbFIcXE5XycnS46yP0srtwKQyyOIikAAAAAAAJRHJNFQOgxDSkrydRQAAAAAAADFQhINpacML98EAAAAAAAVG0k0AAAAAAAAoBAk0QAAAAAAAIBCkEQDAAAAAAAACkESDQAAAAAAACgESTQAAACUmGeffVb16tVTaGioOnbsqM2bN+fbd9GiRUpISFC1atVUrVo1de/evcD+AAAApYkkGgAAAErE8uXLNX78eE2bNk3btm1TmzZt1LNnTx06dMht//Xr1+umm27SF198oY0bNyo2NlZXXnml/vzzz1KOHAAAIC+SaAAAACgR8+bN04gRI5SYmKjm/6+9e4+rqsr/P/4+oICAgAmCdygdKFNRSEQtS/llM04zplPmkCKiTiql0UXNSS0znMxLKqOlI1lhmjk5M1mYkhYRieJlvAXmJXukgI4DCKQg7N8ffj3TUe4Ch8vr+Xicx4Oz9lr7fNY+dfbys9fe6667tGrVKjk6Omrt2rWl1o+Li9PkyZPl7+8vPz8/rVmzRiUlJUpISKjjyAEAAG5GEg0AAAA1rrCwUKmpqQoJCTGX2djYKCQkRMnJyZXaR0FBgYqKinTbbbeVuv3KlSvKzc21eAEAANQWkmiwDsOwdgQAAKAWXbhwQcXFxfL09LQo9/T0VEZGRqX2MX36dLVr184iEfdL0dHRcnV1Nb86dux4y3EDAACUhSQarOPee0mkAQCAMi1YsEAbNmzQxx9/LAcHh1LrzJw5Uzk5OebXjz/+WMdRAgCApqSZtQNAE+LoKPn7SwcOXHsVFEhOTlYOqvbkF+VbOwSgxjk2d5TJZLJ2GAAaAHd3d9na2iozM9OiPDMzU15eXuW2feONN7RgwQLt2LFDPXr0KLOevb297O3tayReAACAipBEQ90xmaTERKllS2tHUic83/CsuBLQwPTv2F+J4Ykk0gBUyM7OTgEBAUpISNCwYcMkybxIQGRkZJntXn/9dc2fP1/btm1TYGBgHUUL1AP5VbgA6+h4bWwNAKhTJNFQtxr5yd6xuaP6d+yvpB+TrB0KUCuSfkxSQVGBnOwa7yxSADUnKipKYWFhCgwMVJ8+fbR06VLl5+crPDxckjRmzBi1b99e0dHRkqS//OUvmj17ttavXy9vb2/zs9OcnZ3l7OxstX4AdcKzChdg+/e/dnG6kY+tAaC+IYkG1CCTyaTE8EQVFBVYOxSgRuUX5TO7EkCVjRw5UufPn9fs2bOVkZEhf39/xcfHmxcbOHPmjGxs/veI3pUrV6qwsFB/+MMfLPYzZ84czZ07ty5DB+qGo+O1hFhSFS/AJiU1+kejAEB9RBINqGEmk4lZOgAA/J/IyMgyb9/ctWuXxfvTp0/XfkBAfXL9cScFlbwAm59ftRlrAIAaRRINAAAAAKzFZGJGGQA0EDYVVwEAAAAAAACaNpJoAAAAAAAAQAVIogEAAAAAAAAVIIkGAAAAAAAAVIAkGgAAAAAAAFABVueE9eTnV6+do+O1VYwAAAAAAADqSL2YiRYTEyNvb285ODgoKChIKSkpZdZdvXq17r33XrVq1UqtWrVSSEhIufVRj3l6Ss7OVX/de69kGNaOHgAAAAAANCFWT6Jt3LhRUVFRmjNnjvbt26eePXtqyJAhysrKKrX+rl27NGrUKO3cuVPJycnq2LGjHnzwQf300091HDmqxdFR6t//1vaRlCQVFNRMPAAAAEBDlJ9f/ouLzgBQ46yeRFu8eLEmTJig8PBw3XXXXVq1apUcHR21du3aUuvHxcVp8uTJ8vf3l5+fn9asWaOSkhIlJCTUceSoFpNJSkyU8vKq/srMtHb0AAAAQP1Q0V0d3L0BADXOqs9EKywsVGpqqmbOnGkus7GxUUhIiJKTkyu1j4KCAhUVFem2224rdfuVK1d05coV8/vc3NxbCxq3zmSSnJysHQUAAADQsFy/qyMpqeK61+/eYNwNADXGqjPRLly4oOLiYnl6elqUe3p6KiMjo1L7mD59utq1a6eQkJBSt0dHR8vV1dX86tix4y3HDQAAAAB1rjJ3dXD3BgDUmga9OueCBQu0YcMG7dq1Sw4ODqXWmTlzpqKioszvc3NzSaQBAAAAaJi4q6PJyi/Kt3YIqEOOzR1lMpmsHQZuYNUkmru7u2xtbZV5w9WSzMxMeXl5ldv2jTfe0IIFC7Rjxw716NGjzHr29vayt7evkXgBAAAAALAGzzc8K66ERqN/x/5KDE8kkVbPWPV2Tjs7OwUEBFgsCnB9kYDg4OAy273++uuaN2+e4uPjFRgYWBehAgD+T35RvvILa+5l8NBjAACAUjk2d1T/jv2tHQasIOnHJBUUFVg7DNzA6rdzRkVFKSwsTIGBgerTp4+WLl2q/Px8hYeHS5LGjBmj9u3bKzo6WpL0l7/8RbNnz9b69evl7e1tfnaas7OznJ2drdYPAGgqavoqKFfZAAAASmcymZQYnkgypQnJL8pn1mE9ZvUk2siRI3X+/HnNnj1bGRkZ8vf3V3x8vHmxgTNnzsjG5n8T5lauXKnCwkL94Q9/sNjPnDlzNHfu3LoMHQCajOtXQZN+rMRqYFV0/Sqbkx3PdwEAALiRyWRinATUE1ZPoklSZGSkIiMjS922a9cui/enT5+u/YAAABZq4yooV9kAAAAANCT1IokGAKj/uAoKAAAAoCkjiYaGKb8Kyzs7Ol5bChwAAAAAAKCaSKKhYfKswi1g/ftLiYkk0gAAANC0VOXCc03iIjaARookGhoOR8drCbGkKj7YPClJKiiQnLgNDQAAAE1IVS481yQuYgNopEiioeEwma6djAsq+WDz/HzrDRwAAAAAa6juheeaxEVsAI0USTQ0LCYTJ2MAAACgLFW98FyTuIgNoJEjiQYAAAAAjQkXngGgVthYOwAAAAAAAACgviOJBgAAAAAAAFSAJBoAAAAAAABQAZJoAAAAAAAAQAVIogEAAAAAAAAVIIkGAAAAAAAAVKCZtQMAAAAAADQy+fnWjgCV4egomUzWjgJoMEiioWmoDydxTlAAAABoKjw9rR0BKqN/fykxkX+nAJVEEg1NQ304iXOCAsqUX1QPEt1oNBybO8rEby3qgdOnT8vHx0f79++Xv79/tfczd+5cbdmyRQcOHKix2IBa4eh4bcyblGTtSFBZSUlSQYHk5GTtSIAGgSQaGq/6dhLnBAWUyfONepDoRqORNzNPTnb81qJmZWRkaP78+dq6dat++ukntWnTRv7+/po2bZoGDx5capuOHTvq3Llzcnd3r+Noa09MTIwWLlyojIwM9ezZU8uXL1efPn3KrP/OO+8oPDzcosze3l6XL1+2KDt27JimT5+uL7/8UlevXtVdd92lzZs3q1OnTrXSD9QSk+naReOCAmtHgork59ePiQZAA0MSDY1XfTmJc4ICSuXY3FH9O/ZX0o/1JNENAGU4ffq0+vfvLzc3Ny1cuFDdu3dXUVGRtm3bpilTpui7774rtZ2tra28vLzqONras3HjRkVFRWnVqlUKCgrS0qVLNWTIEKWlpalNmzZltnNxcVFaWpr5/Y0zRU+cOKEBAwYoIiJCL7/8slxcXHTkyBE5ODjUWl9Qi0wmLhoDaLRIoqFx4yQO1Fsmk0mJ4YkqKOJqNWqWY3NHa4eARmby5MkymUxKSUmR0y/GFd26ddO4cePKbHfj7Zy7du3SAw88oB07dmj69Ok6evSo/P39FRsbK19fX3O7BQsWaMmSJSooKNBjjz0mDw+Pm/a9Zs0aLVq0SKdOnZK3t7eefvppTZ48WZI0btw47d27V3v27JG9vb0KCwsVFBSk7t2769133632cVi8eLEmTJhgnlm2atUqbd26VWvXrtWMGTPKbGcymcpNJs6aNUu/+c1v9Prrr5vL7rjjjmrHCQBAbSGJBgCwGpPJxG13AOq1ixcvKj4+XvPnz7dIoF3n5uZW5X3OmjVLixYtkoeHh5588kmNGzdOSf/3+IkPP/xQc+fOVUxMjAYMGKD33ntPy5Yt0+23325uHxcXp9mzZ2vFihXq1auX9u/frwkTJsjJyUlhYWFatmyZevbsqRkzZmjJkiWaNWuWsrOztWLFijJjun7bpWEYpW4vLCxUamqqZs6caS6zsbFRSEiIkpOTy+1vXl6eOnfurJKSEvXu3VuvvfaaunXrJkkqKSnR1q1b9cILL2jIkCHav3+/fHx8NHPmTA0bNqyyhxQAgDpBEg0AAAAow/fffy/DMOTn51dj+5w/f74GDhwoSZoxY4aGDh2qy5cvy8HBQUuXLlVERIQiIiIkSa+++qp27Nhh8QyxOXPmaNGiRRo+fLgkycfHR0ePHtVbb72lsLAwOTs76/3339fAgQPVsmVLLV26VDt37pSLi0uZMbm6ulrMhrvRhQsXVFxcLM8bHlHh6elZ5u2skuTr66u1a9eqR48eysnJ0RtvvKF+/frpyJEj6tChg7KyspSXl6cFCxbo1Vdf1V/+8hfFx8dr+PDh2rlzp/k4AQBQH9hYOwAAAACgviprZtaNnnzySTk7O5tf5enRo4f577Zt20qSsrKyJF17wH5QUJBF/eDgYPPf+fn5OnHihCIiIiw+79VXX9WJEycs2jz33HOaN2+enn32WQ0YMKDcmB555JFyk2HVFRwcrDFjxsjf318DBw7U3//+d3l4eOitt96SdG0mmiT9/ve/1zPPPCN/f3/NmDFDv/3tb7Vq1aoajwcAgFvBTDQAAACgDF27dpXJZKowwfTKK6/oueeeq9Q+mzdvbv77+kP2ryeTKpKXlydJWr169U3JNltbW/PfJSUlSkpKkq2trb7//vtK7bs87u7usrW1VWZmpkV5ZmZmlRZPaN68uXr16mWOyd3dXc2aNdNdd91lUe/OO+/U119/fctxAwBQk5iJBgAAAJThtttu05AhQxQTE6P8/PybtmdnZ0uS2rRpoy5duphf1XXnnXdq9+7dFmXffvut+W9PT0+1a9dOJ0+etPi8Ll26yMfHx1xv4cKF+u677/Tll18qPj5esbGx1Y5Jkuzs7BQQEKCEhARzWUlJiRISEixmylWkuLhYhw4dMs/As7Oz0z333GOxeqckpaenq3PnzrcUMwAANY0kGgAAAFCOmJgYFRcXq0+fPtq8ebOOHz+uY8eOadmyZVVKIFXG1KlTtXbtWsXGxio9PV1z5szRkSNHLOq8/PLLio6O1rJly5Senq5Dhw4pNjZWixcvliTt379fs2fP1po1a9S/f38tXrxYU6dO1cmTJ8v83I8//rjC575FRUVp9erVWrdunY4dO6ZJkyYpPz/fvFqnJI0ZM8Zi8YFXXnlFn3/+uU6ePKl9+/bpiSee0A8//KDx48eb6zz//PPauHGjVq9ere+//14rVqzQv/71L/NqowAA1BfczgkAAACU4/bbb9e+ffs0f/58Pfvsszp37pw8PDwUEBCglStX1uhnjRw5UidOnNALL7ygy5cva8SIEZo0aZK2bdtmrjN+/Hg5Ojpq4cKFev755+Xk5KTu3btr2rRpunz5sp544gmNHTtWDz/8sCRp4sSJ2rp1q0aPHq2vvvrK4rbP63Jycm6aDVZabOfPn9fs2bOVkZEhf39/xcfHWyw2cObMGdnY/O86/X//+19NmDBBGRkZatWqlQICAvTNN99Y3L75yCOPaNWqVYqOjtbTTz8tX19fbd68ucLnuAEAUNdMRmWfltpI5ObmytXVVTk5OeWuUATUmPx86foDhvPyJCcn68YDAKgWxhD1H98RAFQS/0apt/IL8+Ucfe27yZuZJyc7vpu6UNkxBDPRgLpUyrNU6i1HR+n/HnYMAAAAAEBTRxINqEu/uN2h3uvfX0pMJJEGAAAAAIBYWACofY6O1xJSDU1SklRQYO0oAAAAAACoF5iJBtQ2k+najK6GkpDKz29YM+YAAAAAAKgDJNGAumAy8bBOAAAAAAAaMG7nBAAAAAAAACpAEg0AAAAAAACoALdzWsnp06fl4+Oj/fv3y9/fv9r7mTt3rrZs2aIDBw7UWGwAAAAAAMC68ovyrR1CvePY3FEmk8lqn08SrQZkZGRo/vz52rp1q3766Se1adNG/v7+mjZtmgYPHlxqm44dO+rcuXNyd3ev42hrT0xMjBYuXKiMjAz17NlTy5cvV58+fcqs/8477yg8PNyizN7eXpcvXza/L+t/jtdff13PP/98zQQOAAAAAEA94/kGC77dKG9mnpzsrPe8cW7nvEWnT59WQECAvvjiCy1cuFCHDh1SfHy8HnjgAU2ZMqXMdra2tvLy8lKzZo0jj7lx40ZFRUVpzpw52rdvn3r27KkhQ4YoKyur3HYuLi46d+6c+fXDDz9YbP/ltnPnzmnt2rUymUwaMWJEbXYHAAAAAIA659jcUf079rd2GChD48jgWNHkyZNlMpmUkpIip1+svtitWzeNGzeuzHY33s65a9cuPfDAA9qxY4emT5+uo0ePyt/fX7GxsfL19TW3W7BggZYsWaKCggI99thj8vDwuGnfa9as0aJFi3Tq1Cl5e3vr6aef1uTJkyVJ48aN0969e7Vnzx7Z29ursLBQQUFB6t69u959991qH4fFixdrwoQJ5pllq1at0tatW7V27VrNmDGjzHYmk0leXl5lbr9x2z/+8Q898MADuv3226sdKwAAAAAA9ZHJZFJieKIKigqsHUq95Njc0aqfTxLtFly8eFHx8fGaP3++RQLtOjc3tyrvc9asWVq0aJE8PDz05JNPaty4cUpKSpIkffjhh5o7d65iYmI0YMAAvffee1q2bJlFQikuLk6zZ8/WihUr1KtXL+3fv18TJkyQk5OTwsLCtGzZMvXs2VMzZszQkiVLNGvWLGVnZ2vFihVlxnT9tkvDMErdXlhYqNTUVM2cOdNcZmNjo5CQECUnJ5fb37y8PHXu3FklJSXq3bu3XnvtNXXr1q3UupmZmdq6davWrVtX7j4BAAAAAGioTCaTVW9ZRNlIot2C77//XoZhyM/Pr8b2OX/+fA0cOFCSNGPGDA0dOlSXL1+Wg4ODli5dqoiICEVEREiSXn31Ve3YscPiGWJz5szRokWLNHz4cEmSj4+Pjh49qrfeekthYWFydnbW+++/r4EDB6ply5ZaunSpdu7cKRcXlzJjcnV1tZgNd6MLFy6ouLhYnp6W92t7enrqu+++K7Odr6+v1q5dqx49eignJ0dvvPGG+vXrpyNHjqhDhw431V+3bp1atmxp7hsAAAAAAEBdIYl2C8qamXWjJ598Uu+//775fV5eXpl1e/ToYf67bdu2kqSsrCx16tRJx44d05NPPmlRPzg4WDt37pQk5efn68SJE4qIiNCECRPMda5evSpXV1eLNs8995zmzZun6dOna8CAAeXG/8gjj+iRRx6pRE+rJjg4WMHBweb3/fr105133qm33npL8+bNu6n+2rVrFRoaKgcHhxqPBWXIbwSrwTg6SlZcvQUAgOoaO3assrOztWXLFmuHAgAARBLtlnTt2lUmk6nc2VaS9Morr+i5556r1D6bN29u/vv6ypQlJSWVans9Obd69WoFBQVZbLO1tTX/XVJSoqSkJNna2ur777+v1L7L4+7uLltbW2VmZlqUZ2Zmlvu8sxs1b95cvXr1KjWmxMREpaWlaePGjbccL6rAsxGsBtO/v5SYSCINAIBbcPHiRT311FP617/+JRsbG40YMUJvvvmmnJ2dy2zz9ttva/369dq3b58uXbqk//73vzc97mTfvn2aPn269uzZI1tbW40YMUKLFy8ud78AAFgLq3Pegttuu01DhgxRTEyM8kuZsZOdnS1JatOmjbp06WJ+Vdedd96p3bt3W5R9++235r89PT3Vrl07nTx50uLzunTpIh8fH3O9hQsX6rvvvtOXX36p+Ph4xcbGVjsmSbKzs1NAQIASEhLMZSUlJUpISLCYaVaR4uJiHTp0yDwD75f+9re/KSAgQD179rylWFEJjo7XEk+NRVKSVMBDOQEAuBWhoaE6cuSItm/frk8++URfffWVJk6cWG6bgoICPfTQQ3rxxRdL3X727FmFhISoS5cu2r17t+Lj43XkyBGNHTu2FnoAAMCtI4l2i2JiYlRcXKw+ffpo8+bNOn78uI4dO6Zly5ZVKYFUGVOnTtXatWsVGxur9PR0zZkzR0eOHLGo8/LLLys6OlrLli1Tenq6Dh06pNjYWC1evFiStH//fs2ePVtr1qxR//79tXjxYk2dOlUnT54s83M//vjjCp/7FhUVpdWrV2vdunU6duyYJk2apPz8fPNqnZI0ZswYi8UHXnnlFX3++ec6efKk9u3bpyeeeEI//PCDxo8fb7Hv3Nxcbdq06aZy1BKT6drMrby8hv26YWYkAADVdf/99ysyMlKRkZFydXWVu7u7XnrppTIf7ZGenl7q3QpLlizRHXfcIenaxcOIiAj5+PioRYsW8vX11ZtvvlluHN7e3lq6dKlFmb+/v+bOnWt+n52drfHjx8vDw0MuLi4aNGiQDh48WPVO/8KxY8cUHx+vNWvWKCgoSAMGDNDy5cu1YcMGnT17tsx206ZN04wZM9S3b99St3/yySdq3ry5YmJi5Ovrq3vuuUerVq3S5s2ba+RuCQAAahq3c96i22+/Xfv27dP8+fP17LPP6ty5c/Lw8FBAQIBWrlxZo581cuRInThxQi+88IIuX76sESNGaNKkSdq2bZu5zvjx4+Xo6KiFCxfq+eefl5OTk7p3765p06bp8uXLeuKJJzR27Fg9/PDDkqSJEydq69atGj16tL766iuL2z6vy8nJUVpaWoWxnT9/XrNnz1ZGRob8/f0VHx9vsdjAmTNnZGPzv7ztf//7X02YMEEZGRlq1aqVAgIC9M033+iuu+6y2PeGDRtkGIZGjRpVreOGajCZpFJWnAUAoKlat26dIiIilJKSor1792rixInq1KmTxXNor/vVr36lwMBAxcXFWTznNS4uTn/84x8lXZu136FDB23atEmtW7fWN998o4kTJ6pt27Z67LHHqh3no48+qhYtWuizzz6Tq6ur3nrrLQ0ePFjp6em67bbbSm1z//33y9vbW++8806p25OTk+Xm5qbAwEBzWUhIiGxsbLR79+5qPzv3ypUrsrOzsxgftmjRQpL09ddf39IdHAAA1AaTUdmn4zcSubm5cnV1VU5OTrkrUgJo4PLzpevPU8nLIykI4JYxhqj/aus7uv/++5WVlaUjR46Yn1k7Y8YM/fOf/9TRo0dLbbN06VKtWLHCPKMqPT1dvr6+OnbsWJkz/CMjI5WRkaGPPvpI0s0LC3h7e2vatGmaNm2auY2/v7+GDRumuXPn6uuvv9bQoUOVlZUle3t7c50uXbrohRdeKPP2yzFjxqh9+/aKjo4udftrr72mdevW3XRRtU2bNnr55Zc1adKkUttdt2vXLj3wwAM3PRPtyJEj8vf312uvvaapU6cqPz9fEyZM0ObNm/Xaa69Z3MEAoIYxVgYsVHYMwe2cAAAAQAX69u1rTqBJ11YZP378uIqLi0ut//jjj+v06dPm59fGxcWpd+/eFgm0mJgYBQQEyMPDQ87Oznr77bd15syZasd48OBB5eXlqXXr1nJ2dja/Tp06pRMnTpTZ7t133y0zgVabunXrpnXr1mnRokVydHSUl5eXfHx85OnpaTE7DQCA+oLbOQEAAIAa5uXlpUGDBmn9+vXq27ev1q9fbzFja8OGDXruuee0aNEiBQcHq2XLllq4cOFNi0j9ko2NzU3PYSsqKjL/nZeXp7Zt22rXrl03tb1xVcyq9iUrK8ui7OrVq7p48WKVVmIvzR//+Ef98Y9/VGZmppycnGQymbR48WLdfvvtt7RfAABqA0k0AAAAoAKlrZDetWvXUp8ne11oaKheeOEFjRo1SidPntTjjz9u3paUlKR+/fpp8uTJ5rLyZotJkoeHh86dO2d+n5ubq1OnTpnf9+7dWxkZGWrWrJm8vb0r27UKBQcHKzs7W6mpqQoICJAkffHFFyopKVFQUFCNfMb15+iuXbtWDg4O+n//7//VyH4BAKhJzJMGAAAAKnDmzBlFRUUpLS1NH3zwgZYvX66pU6eW22b48OG6dOmSJk2apAceeEDt2rUzb+vatav27t2rbdu2KT09XS+99JL27NlT7v4GDRqk9957T4mJiTp06JDCwsIsknghISEKDg7WsGHD9Pnnn+v06dP65ptvNGvWLO3du7fM/d64gvqN7rzzTj300EOaMGGCUlJSlJSUpMjISD3++OPmPv3000/y8/NTSkqKuV1GRoYOHDhgfi7coUOHdODAAV28eNFcZ8WKFdq3b5/S09MVExOjyMhIRUdH39LMOQAAagsz0QAAAIAKjBkzRj///LP69OkjW1tbTZ06tcwH9V/XsmVLPfzww/rwww+1du1ai21/+tOftH//fo0cOVImk0mjRo3S5MmT9dlnn5W5v5kzZ+rUqVP67W9/K1dXV82bN89iJprJZNKnn36qWbNmKTw8XOfPn5eXl5fuu+8+ixXTb3TjCuqliYuLU2RkpAYPHiwbGxuNGDFCy5YtM28vKipSWlqaCgoKzGWrVq3Syy+/bH5/3333SZJiY2M1duxYSVJKSormzJmjvLw8+fn56a233tLo0aPLjQUAAGthdU4AjRMrDgGoYYwh6r/aXJ3T399fS5curbF9AoBVMVYGLLA6JwAAAAAAAFBDSKIBAAAAAAAAFeCZaAAav/x8a0eAmuboKJlM1o4CQBOxa9cua4cAAADqAZJoABq/ch6mjAaqf38pMZFEGgAAAIA6w+2cABonR8driRY0TklJ0i9WgAMAAACA2sZMNACNk8l0baYSiZbGJT+fmYUAAAAArIIkGoDGy2RiuW4AAAAAQI3gds4GauzYsRo2bJi1wwAAAAAAAGgSSKLhll28eFGhoaFycXGRm5ubIiIilJeXV26by5cva8qUKWrdurWcnZ01YsQIZWZmllr3P//5jzp06CCTyaTs7Oxa6AEAAAAAAED5SKLhloWGhurIkSPavn27PvnkE3311VeaOHFiuW2eeeYZ/etf/9KmTZv05Zdf6uzZsxo+fHipdSMiItSjR4/aCB0AAAAAAKBSSKLdovvvv1+RkZGKjIyUq6ur3N3d9dJLL8kwjFLrp6eny2Qy6bvvvrMoX7Jkie644w5JUnFxsSIiIuTj46MWLVrI19dXb775ZrlxeHt7a+nSpRZl/v7+mjt3rvl9dna2xo8fLw8PD7m4uGjQoEE6ePBg1Tv9C8eOHVN8fLzWrFmjoKAgDRgwQMuXL9eGDRt09uzZUtvk5OTob3/7mxYvXqxBgwYpICBAsbGx+uabb/Ttt99a1F25cqWys7P13HPP3VKcAAAAAAAAt4IkWg1Yt26dmjVrppSUFL355ptavHix1qxZU2rdX/3qVwoMDFRcXJxFeVxcnP74xz9KkkpKStShQwdt2rRJR48e1ezZs/Xiiy/qww8/vKU4H330UWVlZemzzz5TamqqevfurcGDB+vixYtltrn//vs1duzYMrcnJyfLzc1NgYGB5rKQkBDZ2Nho9+7dpbZJTU1VUVGRQkJCzGV+fn7q1KmTkpOTzWVHjx7VK6+8onfffVc2NvynCgAAAAAArIfMRA3o2LGjlixZIl9fX4WGhuqpp57SkiVLyqwfGhqqDz74wPw+PT1dqampCg0NlSQ1b95cL7/8sgIDA+Xj46PQ0FCFh4ffUhLt66+/VkpKijZt2qTAwEB17dpVb7zxhtzc3PTRRx+V2a5Tp05q27ZtmdszMjLUpk0bi7JmzZrptttuU0ZGRplt7Ozs5ObmZlHu6elpbnPlyhWNGjVKCxcuVKdOnSrZSwAAAAAAgNpBEq0G9O3bVyaTyfw+ODhYx48fV3Fxcan1H3/8cZ0+fdp862JcXJx69+4tPz8/c52YmBgFBATIw8NDzs7Oevvtt3XmzJlqx3jw4EHl5eWZH+R//XXq1CmdOHGizHbvvvuuoqOjq/251TVz5kzdeeedeuKJJ+r8swEAAAAAAG7UzNoBNEVeXl4aNGiQ1q9fr759+2r9+vWaNGmSefuGDRv03HPPadGiRQoODlbLli21cOHCMm+PlCQbG5ubnsNWVFRk/jsvL09t27bVrl27bmp744ywqvYlKyvLouzq1au6ePGivLy8ymxTWFio7Oxsi8/OzMw0t/niiy906NAh8yy5631zd3fXrFmz9PLLL1c7ZgAAAAAAgKoiiVYDbkxuffvtt+ratatsbW3LbBMaGqoXXnhBo0aN0smTJ/X444+btyUlJalfv36aPHmyuay82WKS5OHhoXPnzpnf5+bm6tSpU+b3vXv3VkZGhpo1ayZvb+/Kdq1CwcHBys7OVmpqqgICAiRdS4CVlJQoKCio1DYBAQFq3ry5EhISNGLECElSWlqazpw5o+DgYEnS5s2b9fPPP5vb7NmzR+PGjVNiYqJ5AQYAAAAAAIC6wu2cNeDMmTOKiopSWlqaPvjgAy1fvlxTp04tt83w4cN16dIlTZo0SQ888IDatWtn3ta1a1ft3btX27ZtU3p6ul566SXt2bOn3P0NGjRI7733nhITE3Xo0CGFhYVZJPFCQkIUHBysYcOG6fPPP9fp06f1zTffaNasWdq7d2+Z+x0zZoxmzpxZ5vY777xTDz30kCZMmKCUlBQlJSUpMjJSjz/+uLlPP/30k/z8/JSSkiJJcnV1VUREhKKiorRz506lpqYqPDxcwcHB6tu3ryTpjjvu0N13321++fj4mD/vxmewAQAAAAAA1DZmotWAMWPG6Oeff1afPn1ka2urqVOnauLEieW2admypR5++GF9+OGHWrt2rcW2P/3pT9q/f79Gjhwpk8mkUaNGafLkyfrss8/K3N/MmTN16tQp/fa3v5Wrq6vmzZtnMRPNZDLp008/1axZsxQeHq7z58/Ly8tL9913nzw9Pcvc75kzZypcGTMuLk6RkZEaPHiwbGxsNGLECC1btsy8vaioSGlpaSooKDCXLVmyxFz3ypUrGjJkiP7617+W+zkAAAAAAADWYjJufJBWI5ebmytXV1fl5OTIxcXllvd3//33y9/fX0uXLr314AAA5cvPl5ydr/2dlyc5OVk3HjQpNT2GQM3jOwKASmJMBVio7BiC2zkBAABQa2JiYuTt7S0HBwcFBQWZH+9Qlk2bNsnPz08ODg7q3r27Pv300zqKFAAAoHwk0QAAAFArNm7cqKioKM2ZM0f79u1Tz549NWTIkJtW9r7um2++0ahRoxQREaH9+/dr2LBhGjZsmA4fPlzHkQMAANyM2zkBAA3HL289yMxsWLceODpKJpO1o8AtYAxRdUFBQbrnnnu0YsUKSVJJSYk6duyop556SjNmzLip/siRI5Wfn69PPvnEXNa3b1/5+/tr1apVFX4e3xEAVBK3cwIWKjuGYGEBAEDDVM6iKPUSA1Q0MYWFhUpNTbVY5dvGxkYhISFKTk4utU1ycrKioqIsyoYMGaItW7aUWv/KlSu6cuWK+X1ubu6tBw4AAFAGbucEADQcjo5S//7WjgJAJVy4cEHFxcU3rQLu6empjIyMUttkZGRUqX50dLRcXV3Nr44dO9ZM8AAAAKVgJhoAoOEwmaTERKmgwNqRVJ2jo7UjABqdmTNnWsxcy83NJZEGAJXh6Hhtlvz1vwFUCkk0AEDDYjJxWyTQALi7u8vW1laZmZkW5ZmZmfLy8iq1jZeXV5Xq29vby97evmYCBoCmhPEUUC3czgkAAIAaZ2dnp4CAACUkJJjLSkpKlJCQoODg4FLbBAcHW9SXpO3bt5dZHwAAoC4xEw0AAAC1IioqSmFhYQoMDFSfPn20dOlS5efnKzw8XJI0ZswYtW/fXtHR0ZKkqVOnauDAgVq0aJGGDh2qDRs2aO/evXr77bet2Q0AAABJJNEAAABQS0aOHKnz589r9uzZysjIkL+/v+Lj482LB5w5c0Y2Nv+7MaJfv35av369/vznP+vFF19U165dtWXLFt19993W6gIAAICZyTAMw9pB1KXc3Fy5uroqJydHLi4u1g4HAAA0EIwh6j++IwAAUB2VHUPwTDQAAAAAAACgAiTRAAAAAAAAgAqQRAMAAAAAAAAqQBINAAAAAAAAqABJNAAAAAAAAKACJNEAAAAAAACACpBEAwAAAAAAACpAEg0AAAAAAACoAEk0AAAAAAAAoAL1IokWExMjb29vOTg4KCgoSCkpKeXW37Rpk/z8/OTg4KDu3bvr008/raNIAQAAAAAA0BRZPYm2ceNGRUVFac6cOdq3b5969uypIUOGKCsrq9T633zzjUaNGqWIiAjt379fw4YN07Bhw3T48OE6jhwAAAAAAABNhckwDMOaAQQFBemee+7RihUrJEklJSXq2LGjnnrqKc2YMeOm+iNHjlR+fr4++eQTc1nfvn3l7++vVatWVfh5ubm5cnV1VU5OjlxcXGquIwAAoFFjDFH/8R0BAIDqqOwYwqoz0QoLC5WamqqQkBBzmY2NjUJCQpScnFxqm+TkZIv6kjRkyJAy61+5ckW5ubkWLwAAAAAAAKAqrJpEu3DhgoqLi+Xp6WlR7unpqYyMjFLbZGRkVKl+dHS0XF1dza+OHTvWTPAAAAAAAABoMqz+TLTaNnPmTOXk5JhfP/74o7VDAgAAAAAAQAPTzJof7u7uLltbW2VmZlqUZ2ZmysvLq9Q2Xl5eVapvb28ve3v7mgkYAAAAAAAATZJVZ6LZ2dkpICBACQkJ5rKSkhIlJCQoODi41DbBwcEW9SVp+/btZdYHAAAAAAAAbpVVZ6JJUlRUlMLCwhQYGKg+ffpo6dKlys/PV3h4uCRpzJgxat++vaKjoyVJU6dO1cCBA7Vo0SINHTpUGzZs0N69e/X2229X6vOuL0bKAgMAAKAqro8drLywOcrBOA8AAFRHZcd5Vk+ijRw5UufPn9fs2bOVkZEhf39/xcfHmxcPOHPmjGxs/jdhrl+/flq/fr3+/Oc/68UXX1TXrl21ZcsW3X333ZX6vEuXLkkSCwwAAIBquXTpklxdXa0dBkrBOA8AANyKisZ5JqOJXU4tKSnR2bNn1bJlS5lMpmrvJzc3Vx07dtSPP/4oFxeXGoyw/mvKfZeadv/pO31van2Xmnb/6btl3w3D0KVLl9SuXTuLC3yoP2pqnHddU/5/oDo4XpXHsaoajlflcayqhuNVeY39WFV2nGf1mWh1zcbGRh06dKix/bm4uDTK/4Aqoyn3XWra/afv9L0pasr9p+//6zsz0Oq3mh7nXdeU/x+oDo5X5XGsqobjVXkcq6rheFVeYz5WlRnncRkVAAAAAAAAqABJNAAAAAAAAKACJNGqyd7eXnPmzJG9vb21Q6lzTbnvUtPuP32n701RU+4/fW+afcf/8N9B1XC8Ko9jVTUcr8rjWFUNx6vyOFbXNLmFBQAAAAAAAICqYiYaAAAAAAAAUAGSaAAAAAAAAEAFSKIBAAAAAAAAFSCJBgAAAAAAAFSAJFo1xMTEyNvbWw4ODgoKClJKSoq1Q6oRX331lR5++GG1a9dOJpNJW7ZssdhuGIZmz56ttm3bqkWLFgoJCdHx48ct6ly8eFGhoaFycXGRm5ubIiIilJeXV4e9qLro6Gjdc889atmypdq0aaNhw4YpLS3Nos7ly5c1ZcoUtW7dWs7OzhoxYoQyMzMt6pw5c0ZDhw6Vo6Oj2rRpo+eff15Xr16ty65Uy8qVK9WjRw+5uLjIxcVFwcHB+uyzz8zbG3Pfb7RgwQKZTCZNmzbNXNZY+z937lyZTCaLl5+fn3l7Y+33L/3000964okn1Lp1a7Vo0ULdu3fX3r17zdsb62+et7f3Td+9yWTSlClTJDXu7764uFgvvfSSfHx81KJFC91xxx2aN2+efrnGUmP93lE9jXXMVxVNfZx0K5rSuKK6muq5uKo4f5Wvrv4d++9//1v33nuvHBwc1LFjR73++uu13bUaV96xKioq0vTp09W9e3c5OTmpXbt2GjNmjM6ePWuxj6ZyrMpkoEo2bNhg2NnZGWvXrjWOHDliTJgwwXBzczMyMzOtHdot+/TTT41Zs2YZf//73w1Jxscff2yxfcGCBYarq6uxZcsW4+DBg8bvfvc7w8fHx/j555/NdR566CGjZ8+exrfffmskJiYaXbp0MUaNGlXHPamaIUOGGLGxscbhw4eNAwcOGL/5zW+MTp06GXl5eeY6Tz75pNGxY0cjISHB2Lt3r9G3b1+jX79+5u1Xr1417r77biMkJMTYv3+/8emnnxru7u7GzJkzrdGlKvnnP/9pbN261UhPTzfS0tKMF1980WjevLlx+PBhwzAad99/KSUlxfD29jZ69OhhTJ061VzeWPs/Z84co1u3bsa5c+fMr/Pnz5u3N9Z+X3fx4kWjc+fOxtixY43du3cbJ0+eNLZt22Z8//335jqN9TcvKyvL4nvfvn27IcnYuXOnYRiN+7ufP3++0bp1a+OTTz4xTp06ZWzatMlwdnY23nzzTXOdxvq9o+oa85ivKpr6OKm6mtq4ojqa8rm4qjh/la8u/h2bk5NjeHp6GqGhocbhw4eNDz74wGjRooXx1ltv1VU3a0R5xyo7O9sICQkxNm7caHz33XdGcnKy0adPHyMgIMBiH03lWJWFJFoV9enTx5gyZYr5fXFxsdGuXTsjOjrailHVvBv/hyopKTG8vLyMhQsXmsuys7MNe3t744MPPjAMwzCOHj1qSDL27NljrvPZZ58ZJpPJ+Omnn+os9luVlZVlSDK+/PJLwzCu9bN58+bGpk2bzHWOHTtmSDKSk5MNw7j2Y2RjY2NkZGSY66xcudJwcXExrly5UrcdqAGtWrUy1qxZ02T6funSJaNr167G9u3bjYEDB5oHu425/3PmzDF69uxZ6rbG3O/rpk+fbgwYMKDM7U3pN2/q1KnGHXfcYZSUlDT6737o0KHGuHHjLMqGDx9uhIaGGobRtL53VKypjPmqinFSxZriuKI6OBdXHuevyqutf8f+9a9/NVq1amXx/+H06dMNX1/fWu5R7Skt4XijlJQUQ5Lxww8/GIbRdI/VL3E7ZxUUFhYqNTVVISEh5jIbGxuFhIQoOTnZipHVvlOnTikjI8Oi766urgoKCjL3PTk5WW5ubgoMDDTXCQkJkY2NjXbv3l3nMVdXTk6OJOm2226TJKWmpqqoqMii735+furUqZNF37t37y5PT09znSFDhig3N1dHjhypw+hvTXFxsTZs2KD8/HwFBwc3mb5PmTJFQ4cOtein1Pi/++PHj6tdu3a6/fbbFRoaqjNnzkhq/P2WpH/+858KDAzUo48+qjZt2qhXr15avXq1eXtT+c0rLCzU+++/r3HjxslkMjX6775fv35KSEhQenq6JOngwYP6+uuv9etf/1pS0/neUbGmPOarSFMeJ1VWUx1XVBXn4srj/FV9NXVskpOTdd9998nOzs5cZ8iQIUpLS9N///vfOupN3cvJyZHJZJKbm5skjpUkNbN2AA3JhQsXVFxcbHFSkyRPT0999913VoqqbmRkZEhSqX2/vi0jI0Nt2rSx2N6sWTPddttt5jr1XUlJiaZNm6b+/fvr7rvvlnStX3Z2duYfjutu7Htpx+b6tvru0KFDCg4O1uXLl+Xs7KyPP/5Yd911lw4cONDo+75hwwbt27dPe/bsuWlbY/7ug4KC9M4778jX11fnzp3Tyy+/rHvvvVeHDx9u1P2+7uTJk1q5cqWioqL04osvas+ePXr66adlZ2ensLCwJvObt2XLFmVnZ2vs2LGSGvd/85I0Y8YM5ebmys/PT7a2tiouLtb8+fMVGhoqqemc61CxpjzmK09THSdVRVMdV1QH5+LK4/xVfTV1bDIyMuTj43PTPq5va9WqVa3Eb02XL1/W9OnTNWrUKLm4uEjiWEkk0QALU6ZM0eHDh/X1119bO5Q65evrqwMHDignJ0cfffSRwsLC9OWXX1o7rFr3448/aurUqdq+fbscHBysHU6dun7lUpJ69OihoKAgde7cWR9++KFatGhhxcjqRklJiQIDA/Xaa69Jknr16qXDhw9r1apVCgsLs3J0dedvf/ubfv3rX6tdu3bWDqVOfPjhh4qLi9P69evVrVs3HThwQNOmTVO7du2a1PcOVFdTHSdVVlMeV1QH5+LK4/yFulZUVKTHHntMhmFo5cqV1g6nXuF2zipwd3eXra3tTSvoZGZmysvLy0pR1Y3r/Suv715eXsrKyrLYfvXqVV28eLFBHJ/IyEh98skn2rlzpzp06GAu9/LyUmFhobKzsy3q39j30o7N9W31nZ2dnbp06aKAgABFR0erZ8+eevPNNxt931NTU5WVlaXevXurWbNmatasmb788kstW7ZMzZo1k6enZ6Pu/y+5ubnpV7/6lb7//vtG/71LUtu2bXXXXXdZlN15553mW1qbwm/eDz/8oB07dmj8+PHmssb+3T///POaMWOGHn/8cXXv3l2jR4/WM888o+joaElN43tH5TTlMV9ZmvI4qbIYV1QN5+LK4/xVfTV1bJrS/5vXE2g//PCDtm/fbp6FJnGsJJJoVWJnZ6eAgAAlJCSYy0pKSpSQkKDg4GArRlb7fHx85OXlZdH33Nxc7d6929z34OBgZWdnKzU11Vzniy++UElJiYKCguo85soyDEORkZH6+OOP9cUXX9w09TQgIEDNmze36HtaWprOnDlj0fdDhw5Z/KBc/8G5cXDQEJSUlOjKlSuNvu+DBw/WoUOHdODAAfMrMDBQoaGh5r8bc/9/KS8vTydOnFDbtm0b/fcuSf3791daWppFWXp6ujp37iypcf/mXRcbG6s2bdpo6NCh5rLG/t0XFBTIxsZy6GNra6uSkhJJTeN7R+U05THfjRgnVR7jiqrhXFx5nL+qr6aOTXBwsL766isVFRWZ62zfvl2+vr4N/vbEX7qeQDt+/Lh27Nih1q1bW2znWEmszllFGzZsMOzt7Y133nnHOHr0qDFx4kTDzc3NYgWdhurSpUvG/v37jf379xuSjMWLFxv79+83r8SxYMECw83NzfjHP/5h/Pvf/zZ+//vfl7o0cK9evYzdu3cbX3/9tdG1a9d6v2zypEmTDFdXV2PXrl3GuXPnzK+CggJznSeffNLo1KmT8cUXXxh79+41goODjeDgYPP268uRP/jgg8aBAweM+Ph4w8PDo0EsRz5jxgzjyy+/NE6dOmX8+9//NmbMmGGYTCbj888/Nwyjcfe9NL9cRcswGm//n332WWPXrl3GqVOnjKSkJCMkJMRwd3c3srKyDMNovP2+LiUlxWjWrJkxf/584/jx40ZcXJzh6OhovP/+++Y6jfU3zzCurTLYqVMnY/r06Tdta8zffVhYmNG+fXvjk08+MU6dOmX8/e9/N9zd3Y0XXnjBXKcxf++omsY85quKpj5OulVNZVxRHU39XFwVnL/KVxf/js3OzjY8PT2N0aNHG4cPHzY2bNhgODo6Gm+99Vad9/dWlHesCgsLjd/97ndGhw4djAMHDlj85v9ypc2mcqzKQhKtGpYvX2506tTJsLOzM/r06WN8++231g6pRuzcudOQdNMrLCzMMIxrywO/9NJLhqenp2Fvb28MHjzYSEtLs9jHf/7zH2PUqFGGs7Oz4eLiYoSHhxuXLl2yQm8qr7Q+SzJiY2PNdX7++Wdj8uTJRqtWrQxHR0fjkUceMc6dO2exn9OnTxu//vWvjRYtWhju7u7Gs88+axQVFdVxb6pu3LhxRufOnQ07OzvDw8PDGDx4sDmBZhiNu++luXGw21j7P3LkSKNt27aGnZ2d0b59e2PkyJHG999/b97eWPv9S//617+Mu+++27C3tzf8/PyMt99+22J7Y/3NMwzD2LZtmyHppv4YRuP+7nNzc42pU6canTp1MhwcHIzbb7/dmDVrlsXAsDF/76i6xjrmq4qmPk66VU1lXFFdTflcXBWcv8pXV/+OPXjwoDFgwADD3t7eaN++vbFgwYK66mKNKe9YnTp1qszf/J07d5r30VSOVVlMhmEYtTrVDQAAAAAAAGjgeCYaAAAAAAAAUAGSaAAAAAAAAEAFSKIBAAAAAAAAFSCJBgAAAAAAAFSAJBoAAAAAAABQAZJoAAAAAAAAQAVIogEAAAAAAAAVIIkGAAAAAAAAVIAkGoB6ZezYsRo2bJjVPn/06NF67bXXyq3j7e2tpUuX1kk8hYWF8vb21t69e+vk8wAAAGoTYz1LjPWAhqWZtQMA0HSYTKZyt8+ZM0dvvvmmDMOoo4gsHTx4UJ9++qlWrlxplc8vjZ2dnZ577jlNnz5dCQkJ1g4HAACgTIz1qo6xHtCwkEQDUGfOnTtn/nvjxo2aPXu20tLSzGXOzs5ydna2RmiSpOXLl+vRRx+1agylCQ0N1bPPPqsjR46oW7du1g4HAACgVIz1qoexHtBwcDsngDrj5eVlfrm6uspkMlmUOTs73zTF//7779dTTz2ladOmqVWrVvL09NTq1auVn5+v8PBwtWzZUl26dNFnn31m8VmHDx/Wr3/9azk7O8vT01OjR4/WhQsXyoytuLhYH330kR5++GGL8qysLD388MNq0aKFfHx8FBcXd1PbxYsXq3v37nJyclLHjh01efJk5eXlSZLy8/Pl4uKijz76yKLNli1b5OTkpEuXLqmwsFCRkZFq27atHBwc1LlzZ0VHR5vrtmrVSv3799eGDRsqfawBAADqGmO9/2GsBzROJNEA1Hvr1q2Tu7u7UlJS9NRTT2nSpEl69NFH1a9fP+3bt08PPvigRo8erYKCAklSdna2Bg0apF69emnv3r2Kj49XZmamHnvssTI/49///rdycnIUGBhoUT527Fj9+OOP2rlzpz766CP99a9/VVZWlkUdGxsbLVu2TEeOHNG6dev0xRdf6IUXXpAkOTk56fHHH1dsbKxFm9jYWP3hD39Qy5YttWzZMv3zn//Uhx9+qLS0NMXFxcnb29uifp8+fZSYmFjdQwgAAFBvMdZjrAc0GAYAWEFsbKzh6up6U3lYWJjx+9//3vx+4MCBxoABA8zvr169ajg5ORmjR482l507d86QZCQnJxuGYRjz5s0zHnzwQYv9/vjjj4YkIy0trdR4Pv74Y8PW1tYoKSkxl6WlpRmSjJSUFHPZsWPHDEnGkiVLyuzbpk2bjNatW5vf796927C1tTXOnj1rGIZhZGZmGs2aNTN27dplGIZhPPXUU8agQYMsPvtGb775puHt7V3mdgAAgPqEsR5jPaAxYiYagHqvR48e5r9tbW3VunVrde/e3Vzm6ekpSearhgcPHtTOnTvNz91wdnaWn5+fJOnEiROlfsbPP/8se3t7iwfiHjt2TM2aNVNAQIC5zM/PT25ubhZtd+zYocGDB6t9+/Zq2bKlRo8erf/85z/mq6V9+vRRt27dtG7dOknS+++/r86dO+u+++6TdO0K6IEDB+Tr66unn35an3/++U3xtWjRwrw/AACAxoSxHmM9oKEgiQag3mvevLnFe5PJZFF2fTBUUlIiScrLy9PDDz+sAwcOWLyOHz9uHszcyN3dXQUFBSosLKxSbKdPn9Zvf/tb9ejRQ5s3b1ZqaqpiYmIkyWJf48eP1zvvvCPp2vT+8PBwc9y9e/fWqVOnNG/ePP3888967LHH9Ic//MHicy5evCgPD48qxQYAANAQMNZjrAc0FCTRADQ6vXv31pEjR+Tt7a0uXbpYvJycnEpt4+/vL0k6evSouczPz09Xr15VamqquSwtLU3Z2dnm96mpqSopKdGiRYvUt29f/epXv9LZs2dv2v8TTzyhH374QcuWLdPRo0cVFhZmsd3FxUUjR47U6tWrtXHjRm3evFkXL140bz98+LB69epVncMBAADQqDDWA2AtJNEANDpTpkzRxYsXNWrUKO3Zs0cnTpzQtm3bFB4eruLi4lLbeHh4qHfv3vr666/NZb6+vnrooYf0pz/9Sbt371ZqaqrGjx+vFi1amOt06dJFRUVFWr58uU6ePKn33ntPq1atumn/rVq10vDhw/X888/rwQcfVIcOHczbFi9erA8++EDfffed0tPTtWnTJnl5eVncSpCYmKgHH3ywBo4OAABAw8ZYD4C1kEQD0Oi0a9dOSUlJKi4u1oMPPqju3btr2rRpcnNzk41N2T9748ePv2lZ89jYWLVr104DBw7U8OHDNXHiRLVp08a8vWfPnlq8eLH+8pe/6O6771ZcXJzFkuW/FBERocLCQo0bN86ivGXLlnr99dcVGBioe+65R6dPn9ann35qjjU5OVk5OTk3TfsHAABoihjrAbAWk2EYhrWDAID64Oeff5avr682btyo4ODgGt//e++9p2eeeUZnz56VnZ1dpduNHDlSPXv21IsvvljjMQEAADQVjPUA3Kpm1g4AAOqLFi1a6N1339WFCxdqdL8FBQU6d+6cFixYoD/96U9VGlQVFhaqe/fueuaZZ2o0JgAAgKaGsR6AW8VMNACoZXPnztX8+fN133336R//+IecnZ2tHRIAAABqCGM9oOkgiQYAAAAAAABUgIUFAAAAAAAAgAqQRAMAAAAAAAAqQBINAAAAAAAAqABJNAAAAAAAAKACJNEAAAAAAACACpBEAwAAAAAAACpAEg0AAAAAAACoAEk0AAAAAAAAoAL/HyNW4PzIeGN1AAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 1500x700 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig, ax = plt.subplots(1,2,figsize=(15,7))\n",
    "ax[0].step(time_axis_low_ttp, prob_axis_low_ttp, where='post',color='green',label='low risk')\n",
    "ax[0].step(time_axis_high_ttp, prob_axis_high_ttp, where='post',color='red',label='high risk')\n",
    "ax[0].set_xlabel('Time (days)')\n",
    "ax[0].set_ylabel('No progression probability')\n",
    "ax[0].set_title('No progression probability along time (TTP)')\n",
    "ax[0].text(0,0.1,f'C-index : {c_index_ttp}')\n",
    "ax[0].text(0,0.05,f'p value : {p_value_ttp}')\n",
    "\n",
    "ax[1].step(time_axis_low_os, prob_axis_low_os, where='post',color='green',label='low risk')\n",
    "ax[1].step(time_axis_high_os, prob_axis_high_os, where='post',color='red',label='high risk')\n",
    "ax[1].set_xlabel('Time (days)')\n",
    "ax[1].set_ylabel('Survival probability')\n",
    "ax[1].set_title('Survival probability along time (OS)')\n",
    "ax[1].text(0,0.1,f'C-index : {c_index_os}')\n",
    "ax[1].text(0,0.05,f'p value : {p_value_os}')\n",
    "\n",
    "plt.legend()\n",
    "plt.savefig('km-survival-curve.png')"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
